1 | Abatacept | Abatacept 36件: Abatacept; Abatacept (aba); Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept (bms-188667); Abatacept (ctla4-ig); Abatacept (iv); Abatacept (sc); Abatacept + csdmard; Abatacept + methotrexate; Abatacept + vaccines; Abatacept active treatment; Abatacept delayed-onset treatment; Abatacept injection; Abatacept placebo; Abatacept prefilled syringe; Abatacept sc; Abatacept subcutaneous; Abatacept, rituximab or tocilizumab; Adalimuab, etanercept, tocilizumab, or abatacept; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Bms 188667 (abatacept); Decrease tocilizumab, abatacept; Device: abatacept combination product (acp); Double-blind abatacept; Drug: abatacept; Etanercepet, rituximab, abatacept, tocilizumab, sarilumab; Intravenous (iv) abatacept; Iv abatacept; Open-label abatacept; Orencia (abatacept); Orencia abatacept; Orencia® (abatacept); Subcutaneous (sc) abatacept; Subcutaneous abatacept; Subcutaneous(sc) abatacept; Tocilizumab, abatacept; | 1件: D03203 D03203 💬 |
2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
2 | ABX-464 | Abx464 4件: Abx464; Abx464 100mg; Abx464 25mg; Abx464 50mg; | - |
- |
- |
046 3件: 46, 96, 97 💬 |
3 | AC-430 | Ac430 1件: Ac430; | - |
- |
- |
046 1件: 46 💬 |
4 | Acacia | - | 1件: D02779 D02779 💬 |
- |
- |
046 1件: 46 💬 |
5 | Acalabrutinib | Acalabrutinib 1件: Acalabrutinib; | 1件: D10893 D10893 💬 |
1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 2件: 46, 61 💬 |
6 | Aceclofenac | Aceclofenac 1件: Aceclofenac; | 1件: D01545 D01545 💬 |
3件: PTGES, PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
7 | Acetaminophen | Acetaminophen 9件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen tablets; Acetaminophen/paracetamol; Multi-modal pain management [acetaminophen + gabapentin]; Oxycodone/acetaminophen; Paracetamol (acetaminophen); Tramadol /acetaminophen; Tramadol hydrochloride + acetaminophen; | 1件: D00217 D00217 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 16件: 3 , 6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
8 | Acetate | 11c-acetate 98件: 11c-acetate; 2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester; 20mg/0.5ml glatiramer acetate; 40 mg glatiramer acetate; 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Abiraterone acetate; Acetate; Bazedoxifene acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Caspofungin acetate; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Cosyntropin acetate; Cyclophosphamide/glatiramer acetate; Delmitide acetate; Depot leuprolide acetate 3.75 mg; Desmopressin acetate; Desmopressin acetate trihydrate; Device: cellulose acetate with petrolatum; Dichloroacetate; Dichloroacetate sodium; Dirucotide acetate; Edratide acetate; Etiprednol dicloacetate; Experimental glatiramer acetate; Flecainide acetate; Glatiramer acetate; Glatiramer acetate (copaxone®); Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (gtr); Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate [ga]; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Gonadorelin acetate and triptorelin acetate; Human interferon beta-1a and glatiramer acetate; Hydrocortisone acetate; Hydrocortisone sodium acetate; L-lysyl-d-prolyl-l-threonine acetate; L-lysyl-d-prolyl-lthreonine acetate, lyophilisate; Lanreotide acetate; Lapaquistat acetate and current lipid-lowering treatment; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate; Leuprorelin acetate 3.75mg injection; Loestrin (norethindrone acetate and ethinyl estradiol); Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Macimorelin acetate; Megestrol acetate; Megestrol acetate tablet; Methylprednisolone acetate; Nomegestrol acetate; Octreotide acetate; Oxaloacetate (oaa); Phosphate and betamethasone acetate, 2 ml.; Plovamer acetate; Plovamer acetate 0.5 milligram (mg); Plovamer acetate 10 mg; Plovamer acetate 20 mg; Plovamer acetate 3 mg; Prednisolone acetate; Prednisone acetate; Prednisone acetate tablets; Procedure: warm compress prior to injection of glatiramer acetate; Sodium acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate; Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Sotrastaurin (inn) acetate; Tetracosactide acetate; Tetracosactide hexaacetate; Tocopherol acetate; Tocopheryl acetate; Triptorelin acetate and gonadorelin acetate; Ulipristal acetate; Zinc acetate; Zinc acetate (20mg/d); Zinc acetate dihydrate; Zuretinol acetate; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; | - |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
9 | Acetylsalicylic acid | Acetylsalicylic acid 2件: Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,; | 1件: D00109 D00109 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 14件: 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬 |
10 | Activated charcoal | - | 1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
11 | Acyclovir | Acyclovir 1件: Acyclovir; | 1件: D00222 D00222 💬 |
- |
- |
013 5件: 13, 28, 46, 53, 60 💬 |
12 | Adalimumab | Adalimumab 76件: Adalimumab; Adalimumab (40 mg); Adalimumab (ada); Adalimumab (d2e7); Adalimumab (humira); Adalimumab (humira®); Adalimumab (up to 9 months exposure); Adalimumab - gp2017; Adalimumab - us licensed humira; Adalimumab 40 mg; Adalimumab 40 mg eow or ew; Adalimumab 40 mg sc every other week; Adalimumab 40 mg subcutaneous (sc) every other week (eow); Adalimumab 40mg q2w; Adalimumab 80 mg; Adalimumab and infliximab; Adalimumab humira; Adalimumab injection; Adalimumab injection [humira]; Adalimumab pfs and pen; Adalimumab prn; Adalimumab with methotrexate; Adalimumab, current formulation; Adalimumab, etanercept, golimumab or infliximab; Adalimumab, new formulation; Adalimumab, plus prednisone; Adalimumab, solution for injection 40 mg/ (0.8 ml) pre-filled syringe; Adalimumab-eu; Adalimumab-pfizer; Amgevita (adalimumab biosimilar ); Anti-tnf therapy (etanercept or adalimumab); Anti-tnf:adalimumab (subcutaneus); Application of adalimumab; Azathioprine or adalimumab and infliximab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Biosimilar product to adalimumab; Ct-p17 sc ai (adalimumab); Db adalimumab 40 mg eow; Db adalimumab 40 mg ew; Device: adalimumab delivered in current autoinjector; Device: adalimumab delivered in current syringe; Device: adalimumab delivered in physiolis autoinjector; Device: adalimumab delivered in physiolis syringe; Diagnostic test: adalimumab serum trough concentration; Diagnostic test: adalimumab trough concentration; Double-blind adalimumab; Etanercept or adalimumab; Fitc-adalimumab; Gp2017 (adalimumab biosimilar); Humira (adalimumab original); Humira (adalimumab); Humira (adalimumab) 40 mg in 0.4 ml s.c. injection; Humira (adalimumab) 40 mg s.c. injection; Humira (adalimumab) 40mg in 0.4 ml s.c. injection; Humira (adalimumab) 40mg in 0.4ml s.c.injection; Humira 40mg solution for injection in pre-filled syringe (adalimumab); Humira ® (adalimumab) 40mg/0.8ml pre-filled syringe; Humira® (adalimumab); Infliximab and adalimumab; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Infliximab, adalimumab, certolizumab pegol; Infliximab, etanercept, adalimumab; Methotrexate,adalimumab; New formulation adalimumab; Ol adalimumab 40 mg; Open-label adalimumab; Open-labeladalimumabrescue; Other: adalimumab; Other: adalimumab treatment; Other: lengthening adalimumab dosing interval; Other: measurement of drug (adalimumab/infliximab); Sb5 (proposed biosimilar to adalimumab); Start adalimumab in monotherapy; Tnf blockers (infliximab, adalimumab, etanercept); Treatment with adalimumab; Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); | 1件: D02597 D02597 💬 |
1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
019 16件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬 |
13 | Adefovir | Adefovir 1件: Adefovir; | 1件: D02768 D02768 💬 |
- |
- |
046 1件: 46 💬 |
14 | Adenine | - | 1件: D00034 D00034 💬 |
- |
- |
046 1件: 46 💬 |
15 | Adenosine phosphate | - | 1件: D02769 D02769 💬 |
4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
16 | Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - |
- |
- |
002 3件: 2 , 6 , 46 💬 |
17 | ADL5859 | Adl5859 1件: Adl5859; | - |
- |
- |
046 1件: 46 💬 |
18 | AK106-001616 | Ak106-001616 1件: Ak106-001616; | - |
- |
- |
046 1件: 46 💬 |
19 | Alemtuzumab | Alemtuzumab 20件: Alemtuzumab; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994); Alemtuzumab (campath ); Alemtuzumab (campath); Alemtuzumab (gz402673); Alemtuzumab 0.2 mg; Alemtuzumab 0.3 mg; Alemtuzumab 12 mg; Alemtuzumab 24 mg; Alemtuzumab and rituximab; Alemtuzumab gz402673; Alemtuzumab immunotherapy; Alemtuzumab injection; Alemtuzumab injection [lemtrada]; Alemtuzumab, rituximab; Campath-1h (alemtuzumab); Filgrastim, alemtuzumab; Transplant conditioning with mobilization and alemtuzumab; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; | 1件: D02802 D02802 💬 |
- |
- |
013 21件: 13, 15, 19, 20, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 💬 |
20 | Alendronic acid | Alendronic acid 1件: Alendronic acid; | 2件: D00939 D00939
D07119 D07119 💬 |
1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
019 7件: 19, 41, 46, 50, 271, 274, 299 💬 |
21 | Alfacalcidol | Alendronate versus alfacalcidol (1-alpha oh vitamin d) 4件: Alendronate versus alfacalcidol (1-alpha oh vitamin d); Alfacalcidol; Alfacalcidol 2 micrograms/ml; Ibandronate+alfacalcidol+calcium; | 1件: D01518 D01518 💬 |
1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 6件: 41, 46, 49, 50, 96, 235 💬 |
22 | Alkaline Phosphatase | Alkaline phosphatase 7件: Alkaline phosphatase; Bovine intesastinal alkaline phosphatase (biap); Bovine intestinal alkaline phosphatase (biap); Bovine-calf alkaline phosphatase (biap); Bovine-calf alkaline phosphatase biap; Human recombinant tissue non-specific alkaline phosphatase fusion protein; S.c. injections of bovine intestinal alkaline phosphatase; | - |
- |
- |
046 4件: 46, 93, 97, 172 💬 |
23 | Allopurinol | Allopurinol 4件: Allopurinol; Allopurinol sandoz 100 mg, tabletten; Allopurinol sodium; Azathioprine and allopurinol; | 1件: D00224 D00224 💬 |
1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 6件: 6 , 46, 57, 66, 96, 97 💬 |
24 | alpha-Linolenic acid | - | - |
- |
- |
046 2件: 46, 286 💬 |
25 | Aluminium | Aluminium 7件: Aluminium; Aluminium hydroxide; Aluminium phosphate; Pertussis filamentous haemagglutinin adsorbed on aluminium hydroxide; Pertussis pertactin adsorbed on aluminium hydroxide; Pertussis toxoid adsorbed on aluminium hydroxide; Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate; | - |
- |
- |
046 1件: 46 💬 |
26 | Aluminium phosphate | Aluminium phosphate 2件: Aluminium phosphate; Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate; | - |
- |
- |
046 1件: 46 💬 |
27 | Aluminum hydroxide | - | 1件: D02416 D02416 💬 |
- |
- |
046 1件: 46 💬 |
28 | AMG 108 | Amg 108 1件: Amg 108; | - |
- |
- |
046 1件: 46 💬 |
29 | Aminopterin | Aminopterin 3件: Aminopterin; Ld-aminopterin; Methylaminopterin; | 1件: D02527 D02527 💬 |
- |
- |
046 1件: 46 💬 |
30 | Amoxapine | Amoxapine 3件: Amoxapine; Amoxapine & dipyridamole; Dipyridamole and amoxapine; | 1件: D00228 D00228 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
046 1件: 46 💬 |
31 | Amoxicillin | Amoxicillin 8件: Amoxicillin; Amoxicillin and clavulanic acid; Amoxicillin and tetracycline; Amoxicillin hydrate; Amoxicillin, metronidazole and tetracycline; Clartihromycin, amoxicillin, and omeprazole; Lansoprazole, amoxicillin, clarithromycin; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); | 3件: D00229 D00229
D02925 D02925
D07452 D07452 💬 |
- |
- |
006 9件: 6 , 19, 46, 63, 84, 96, 97, 222, 299 💬 |
32 | Anakinra | Anakinra 8件: Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra / kineret; Anakinra and peg stnf-r1; Kineret® (anakinra); Kineret® or anakinra; Response to anakinra associated with methotrexate; | 1件: D02934 D02934 💬 |
2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬 |
33 | Angiotensin II | Angiotensin ii 2件: Angiotensin ii; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); | 2件: D00150 D00150
D02014 D02014 💬 |
2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 7件: 17, 19, 46, 66, 86, 222, 224 💬 |
34 | Anifrolumab | Anifrolumab 4件: Anifrolumab; Anifrolumab (medi-546); Anifrolumab 1000 mg; Anifrolumab 300 mg; | 1件: D11082 D11082 💬 |
2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
046 2件: 46, 49 💬 |
35 | Apratastat | Apratastat 1件: Apratastat; | 1件: D08859 D08859 💬 |
2件: ADAM17, MMP13 💬 |
Alzheimer disease 7件: Alzheimer disease, Coronavirus disease - COVID-19, Epithelial cell signaling in Helicobacter pylori infection, IL-17 signaling pathway, Notch signaling pathway, Parathyroid hormone synthesis, secretion and action, Relaxin signaling pathway |
046 1件: 46 💬 |
36 | Apremilast | Apremilast 7件: Apremilast; Apremilast (cc-10004); Apremilast 20 mg; Apremilast 30 mg; Apremilast 30mg; Apremilast tablet 20 mg; Apremilast tablet 30 mg bid; | 1件: D08860 D08860 💬 |
4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 6件: 46, 50, 56, 97, 162, 271 💬 |
37 | Arginine | Ar401959 l-arginine 13件: Ar401959 l-arginine; Arginine; Etrasimod l-arginine; Growth hormone releasing hormone (ghrh) and arginine; L-arginine; Ng-monomethyl-l-arginine; Ng-monomethyl-l-arginine (drug); Other: ghrh plus arginine test; Other: glucose -potentiated arginine (gpa) stimulation tests; Procedure: arginine and clonidine stimulation testing; Procedure: arginine stimulation test after each limb; Procedure: ghrh/arginine stimulation testing; Vasopressin, arginine; | 1件: D02982 D02982 💬 |
- |
- |
046 9件: 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
38 | Artesunate | Artesunate 1件: Artesunate; | 1件: D02482 D02482 💬 |
- |
- |
046 7件: 46, 53, 66, 96, 97, 215, 271 💬 |
39 | Atacicept | Atacicept 9件: Atacicept; Atacicept 150 mg; Atacicept 25 mg; Atacicept 75 mg; Atacicept 75 milligram (mg); Atacicept150mg; Atacicept25mg; Atacicept75mg; Atacicept: with loading dose; | 1件: D09704 D09704 💬 |
2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 49, 66 💬 |
40 | Atorvastatin | Atorvastatin 9件: Atorvastatin; Atorvastatin 10mg; Atorvastatin 20mg; Atorvastatin calcium; Atorvastatin tablet 20 mg; Interferon beta treatment to add-on atorvastatin treatment; Interferon beta-1b/atorvastatin group; Lisinopril, losartan, and atorvastatin; Untreated to atorvastatin treatment; | 3件: D00258 D00258
D00887 D00887
D07474 D07474 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
41 | Azathioprine | Azathioprine 38件: Azathioprine; Azathioprine (aza); Azathioprine (aza) caps; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine (imuran) 50 mg overencapsulated tablet; Azathioprine - ratiopharm 50 mg; Azathioprine / 6 mercaptopurine; Azathioprine 25 mg; Azathioprine and allopurinol; Azathioprine in case of endoscopic recurrence; Azathioprine individualised dose; Azathioprine or 6-mercaptopurine; Azathioprine or adalimumab and infliximab; Azathioprine or mesalazine; Azathioprine or methotrexate; Azathioprine or mycophenolate mofetil; Azathioprine weight-based dose; Azathioprine+enteral nutrition; Azathioprine/prednisone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Continuation of azathioprine; Corticosteroid and azathioprine; Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Early immunosuppressants (azathioprine, methotrexate); Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, azathioprine; Overencapsulated azathioprine (imuran) 50 mg tablet; Prednisone - azathioprine; Products containing azathioprine or 6-mercaptopurine; Rituximab (rtx) and azathioprine (aza); Steroids plus azathioprine; Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil); | 2件: D00238 D00238
D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
42 | AZD-5672 | Azd5672 1件: Azd5672; | - |
- |
- |
046 1件: 46 💬 |
43 | AZD-9056 | Azd9056 2件: Azd9056; Azd9056 hydrochloride; | - |
- |
- |
046 2件: 46, 96 💬 |
44 | Baminercept | Baminercept 3件: Baminercept; Baminercept alfa; Baminercept alfa (bg9924); | 1件: D08866 D08866 💬 |
1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 53, 97 💬 |
45 | Baricitinib | Baricitinib 4件: Baricitinib; Baricitinib, olumiant®; Tofacitinib or baricitinib; Tofacitinib/baricitinib; | 1件: D10308 D10308 💬 |
2件: JAK1, JAK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 33件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
041 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬 |
46 | Belatacept | Belatacept 1件: Belatacept; | 1件: D03222 D03222 💬 |
2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 1件: 46 💬 |
47 | Belimumab | Belimumab 26件: Belimumab; Belimumab 1 mg/kg; Belimumab 10 mg; Belimumab 10 mg/kg; Belimumab 10 mg/kg plus standard therapy; Belimumab 100 mg sc; Belimumab 10mg/kg; Belimumab 200 mg sc; Belimumab 200 mg/ml; Belimumab 4 mg/kg; Belimumab for iv; Belimumab for sc; Belimumab injection; Belimumab injection [benlysta]; Belimumab or benlysta; Belimumab plus early vaccination; Belimumab plus late vaccination; Benlysta (belimumab); Benlysta? (belimumab); Benlysta® (belimumab); Benlysta™ (belimumab); Combination product: belimumab; Device: belimumab autoinjector; Gsk1550188 (belimumab); Prednisone and belimumab; Sc belimumab 200 mg; | 1件: D03068 D03068 💬 |
1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 10件: 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
48 | Benzimidazole | Benzimidazole 3件: Benzimidazole; Benzimidazole,5-methoxy-2-[[(4-methoxy- 3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 h-benzimidazole; Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1 h-benzimidazole; | - |
- |
- |
046 1件: 46 💬 |
49 | Benzylpenicillin | - | 3件: D01053 D01053
D02157 D02157
D02336 D02336 💬 |
- |
- |
046 1件: 46 💬 |
50 | Betamethasone | Betamethasone 6件: Betamethasone; Betamethasone acibutate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Intra-articular compound betamethasone; Intraarticular betamethasone; Phosphate and betamethasone acetate, 2 ml.; | 7件: D00244 D00244
D00972 D00972
D01357 D01357
D01402 D01402
D01637 D01637
D02032 D02032
D02286 D02286 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 6件: 2 , 28, 46, 90, 96, 235 💬 |
51 | Bifenthrin | - | - |
- |
- |
006 2件: 6 , 46 💬 |
52 | Bimekizumab | Bimekizumab 1件: Bimekizumab; | 1件: D11550 D11550 💬 |
2件: IL17A, IL17F 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
046 3件: 46, 97, 271 💬 |
53 | Binetrakin | - | 1件: D03117 D03117 💬 |
- |
- |
046 1件: 46 💬 |
54 | BMS-582949 | Bms-582949 2件: Bms-582949; Bms-582949 and methotrexate; | - |
- |
- |
046 1件: 46 💬 |
55 | BMS-817399 | Bms-817399 1件: Bms-817399; | - |
- |
- |
046 1件: 46 💬 |
56 | BMS-986104 | Bms-986104 1件: Bms-986104; | - |
- |
- |
046 1件: 46 💬 |
57 | BMS-986142 | Bms-986142 6件: Bms-986142; Bms-986142 200mg; Bms-986142 350mg; Bms986142; Methotrexate, leucovorin and bms-986142; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; | - |
- |
- |
046 3件: 46, 53, 160 💬 |
58 | Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) | - | - |
- |
- |
046 1件: 46 💬 |
59 | Bordetella pertussis pertactin antigen | - | - |
- |
- |
046 1件: 46 💬 |
60 | Bordetella pertussis pertactin antigen (formaldehyde inactivated) | - | - |
- |
- |
046 1件: 46 💬 |
61 | Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) | - | - |
- |
- |
046 1件: 46 💬 |
62 | Bortezomib | Bortezomib 8件: Bortezomib; Bortezomib (velcade®); Bortezomib/dexamethasone; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Combination of a single dose anti-cd20 antibody and bortezomib; Cyclophosphamide, bortezomib, and dexamethasone (cybord); Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; | 1件: D03150 D03150 💬 |
1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
63 | Branebrutinib | Branebrutinib 1件: Branebrutinib; | 1件: D11478 D11478 💬 |
1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 3件: 46, 49, 53 💬 |
64 | Bucillamine | Bucillamine 1件: Bucillamine; | 1件: D01809 D01809 💬 |
- |
- |
046 1件: 46 💬 |
65 | Bupivacaine | Bupivacaine 10件: Bupivacaine; Bupivacaine hydrochloride; Bupivacaine hydrochloride 0.5% (marcaine, pfizer); Bupivacaine injection 0.5%; Bupivacaine/epinephrine/dexamethasone; Ercp with bupivacaine infusion; Lap tap bupivacaine/epinephrine; Levobupivacaine; Liposomal bupivacaine; Us tap bupivacaine/epinephrine; | 2件: D01450 D01450
D07552 D07552 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬 |
66 | Buprenorphine | Buprenorphine 2件: Buprenorphine; Buprenorphine transdermal patch; | 2件: D00836 D00836
D07132 D07132 💬 |
2件: OPRK1, OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 2件: 46, 70 💬 |
67 | Butylene glycol | - | 1件: D10695 D10695 💬 |
- |
- |
028 2件: 28, 46 💬 |
68 | Caffeine | Caffeine 6件: Caffeine; Caffeine 100 mg; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Other: caffeine; | 2件: D00528 D00528
D01453 D01453 💬 |
11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
69 | Calcitriol | Calcitriol 6件: Calcitriol; Calcitriol & calcium; Delayed release 6mp or calcitriol vs. purinethol; Other: empiric use of calcium carbonate and calcitriol; Other: pth based calcium carbonate and calcitriol repletion; Rapamycin-calcitriol combination; | 1件: D00129 D00129 💬 |
1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 8件: 37, 46, 49, 66, 96, 158, 235, 326 💬 |
70 | Calcium | Amorphous calcium carbonate 34件: Amorphous calcium carbonate; Ascal(r) / carbasalate calcium; Atorvastatin calcium; Calcitriol & calcium; Calcium; Calcium and cholecalciferol; Calcium and vitamin d combination; Calcium carbonate; Calcium carbonate and alphacalcidol; Calcium carbonate d; Calcium channel blockers; Calcium citrate; Calcium citrate with vitamin d2; Calcium gluconate; Calcium lactate; Calcium levofolinate; Calcium rosuvastatin; Calcium, dietary; Carbasalate calcium; Crestor tablets (calcium rosuvastatin) film-coated tablets; Crystalline calcium supplements; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Low molecular weight heparin calcium injection; Other: calcium stable isotope; Other: determination of calcium intake by a dietician interview; Other: empiric use of calcium carbonate and calcitriol; Other: pth based calcium carbonate and calcitriol repletion; Other: serum calcium concentrations results; Rosuvastatin calcium; Rosuvastatin calcium 40mg; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Vidofludimus calcium; Vidofludimus calcium dihydrate; | - |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
71 | Calcium carbonate | Amorphous calcium carbonate 6件: Amorphous calcium carbonate; Calcium carbonate; Calcium carbonate and alphacalcidol; Calcium carbonate d; Other: empiric use of calcium carbonate and calcitriol; Other: pth based calcium carbonate and calcitriol repletion; | 2件: D00932 D00932
D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
72 | Calcium citrate | Calcium citrate 2件: Calcium citrate; Calcium citrate with vitamin d2; | 1件: D00933 D00933 💬 |
- |
- |
046 3件: 46, 84, 235 💬 |
73 | Calusterone | - | 1件: D03338 D03338 💬 |
1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
046 2件: 46, 71 💬 |
74 | Canakinumab | Acz885 150 mg (canakinumab) 8件: Acz885 150 mg (canakinumab); Canakinumab; Canakinumab (acz885); Canakinumab (company code: acz885d); Canakinumab (investigational); Canakinumab (proposed); Canakinumab (who approval pending); Canakinumab injection [ilaris]; | 1件: D09315 D09315 💬 |
1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 |
75 | Cannabidiol | Avcn583601 (3% cannabidiol cream) 11件: Avcn583601 (3% cannabidiol cream); Cannabidiol; Cannabidiol (cbd); Cannabidiol , synthetic form; Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Cannabidiol botanical drug substance (cbd bds); Cannabidiol capsule 5 mg; Cannabidiol oral solution; Cannabidiol tablet 10 mg; Cannabidiol vaginal suppository; Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd); | 1件: D10915 D10915 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 19件: 2 , 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬 |
76 | Captopril | Captopril 2件: Captopril; Spironolactone captopril carvedilol; | 1件: D00251 D00251 💬 |
1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
006 8件: 6 , 17, 46, 86, 96, 97, 107, 271 💬 |
77 | Carbaspirin calcium | - | 1件: D03385 D03385 💬 |
- |
- |
046 1件: 46 💬 |
78 | Carbonate ion | - | - |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
79 | CCX-354 | Ccx 354 6件: Ccx 354; Ccx 354-c; Ccx-354; Ccx-354-c; Ccx354; Ccx354-c; | - |
- |
- |
046 1件: 46 💬 |
80 | Celecoxib | Celebra (celecoxib) 8件: Celebra (celecoxib); Celecoxib; Celecoxib (celebrex); Celecoxib 200 milligrams; Celecoxib 200mg capsule; Celecoxib 400 milligrams; Celecoxib, celebrex®; Fixed dose combination ciprofloxacin/celecoxib; | 1件: D00567 D00567 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 9件: 2 , 3 , 34, 46, 70, 89, 161, 171, 271 💬 |
81 | Certolizumab pegol | 99mtc-s-hynic certolizumab pegol 18件: 99mtc-s-hynic certolizumab pegol; Certolizumab pegol; Certolizumab pegol (cdp870); Certolizumab pegol (cdp870, czp); Certolizumab pegol (cdp870, tradename cimzia); Certolizumab pegol (cdp870, tradename cimzia)(prefilled syringes at the dose of 200mg); Certolizumab pegol (czp); Certolizumab pegol (czp) 200 mg; Certolizumab pegol (czp) 400 mg; Certolizumab pegol (rinn); Certolizumab pegol + methotrexate (mtx); Certolizumab pegol / cimzia; Certolizumab pegol /cimzia; Certolizumab pegol 200 mg/ml [cimzia]; Certolizumab pegol 400 mg; Cimzia certolizumab pegol 200 mg/ml solution for injection; Infliximab, adalimumab, certolizumab pegol; Pharmacokinetics of certolizumab pegol; | 1件: D03441 D03441 💬 |
1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 6件: 37, 46, 96, 97, 226, 271 💬 |
82 | Cetrorelix | Cetrorelix 1件: Cetrorelix; | 2件: D01685 D01685
D07665 D07665 💬 |
1件: GNRHR 💬 |
GnRH signaling pathway 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
83 | Chicken | Chicken 2件: Chicken; Chicken type ii collagen; | - |
- |
- |
046 1件: 46 💬 |
84 | Chlordiazepoxide | - | 2件: D00267 D00267
D00693 D00693 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
046 1件: 46 💬 |
85 | Chloride ion | - | - |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
86 | Chlorine | - | - |
- |
- |
046 2件: 46, 271 💬 |
87 | Chloroquine | Chloroquine 15件: Chloroquine; Chloroquine diphosphate; Chloroquine diphosphate 250mg; Hydroxychloroquine; Hydroxychloroquine (z0188); Hydroxychloroquine high; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Hydroxychloroquine sulfate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Other: hydroxychloroquine/chloroquine; Sulphasalazine + hydroxychloroquine or prednisolone; Versus hydroxychloroquine; | 3件: D02125 D02125
D02366 D02366
D03469 D03469 💬 |
- |
- |
046 3件: 46, 49, 95 💬 |
88 | Cholecalciferol | 5000 iu of cholecalciferol 11件: 5000 iu of cholecalciferol; Calcium and cholecalciferol; Cholecalciferol; Cholecalciferol (vitamin d3); Cholecalciferol (vitamind3); Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol and c. xanthorrhiza; Cholecalciferol concentrate; Cholecalciferol concentrate (water-dispersible form); Cholecalciferol, vitamin d3; | 1件: D00188 D00188 💬 |
1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 23件: 6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬 |
89 | Chromium | Chromium 2件: Chromium; Diagnostic test: serum metal ion levels determined to monitor changes in chromium and cobalt levels; | - |
- |
- |
046 1件: 46 💬 |
90 | Citalopram | 20mg daily citalopram 8件: 20mg daily citalopram; Bupropion & citalopram; Citalopram; Citalopram 20mg; Escitalopram; Escitalopram oxalate; Escitalopram oxalate antidepressant; Oral escitalopram; | 2件: D00822 D00822
D07704 D07704 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6 , 8 , 13, 18, 46, 127 💬 |
91 | Clazakizumab | Clazakizumab 1件: Clazakizumab; | 1件: D10312 D10312 💬 |
- |
- |
046 2件: 46, 96 💬 |
92 | Clindamycin | Clindamycin 1件: Clindamycin; | 4件: D00277 D00277
D01073 D01073
D01990 D01990
D02132 D02132 💬 |
- |
- |
046 2件: 46, 299 💬 |
93 | Clobetasol | Clobetasol 8件: Clobetasol; Clobetasol 0.05% ointment; Clobetasol 0.05% topical ointment; Clobetasol propionate; Clobetasol propionate + methotrexate; Clobetasol propionate alone; Clobetasol propionate cream treatment; Procedure: clobetasol propionate; | 1件: D07715 D07715 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
039 4件: 39, 46, 51, 162 💬 |
94 | Clobetasol propionate | Clobetasol propionate 5件: Clobetasol propionate; Clobetasol propionate + methotrexate; Clobetasol propionate alone; Clobetasol propionate cream treatment; Procedure: clobetasol propionate; | 2件: D01272 D01272
D07715 D07715 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 2件: 46, 162 💬 |
95 | Clofarabine | Campath, busulfan, clofarabine 3件: Campath, busulfan, clofarabine; Clofarabine; Radiation: fluorine f 18 clofarabine; | 1件: D03546 D03546 💬 |
3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬 |
96 | Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - |
- |
- |
013 2件: 13, 46 💬 |
97 | Cobalt | Cobalt 3件: Cobalt; Device: cobalt™ bone cement; Diagnostic test: serum metal ion levels determined to monitor changes in chromium and cobalt levels; | - |
- |
- |
046 1件: 46 💬 |
98 | Cobiprostone | Cobiprostone 1件: Cobiprostone; | 1件: D08893 D08893 💬 |
- |
- |
046 1件: 46 💬 |
99 | Cod liver oil | Cod liver oil 1件: Cod liver oil; | 1件: D03578 D03578 💬 |
- |
- |
046 1件: 46 💬 |
100 | Cod, unspecified | - | - |
- |
- |
046 1件: 46 💬 |
101 | Colchicine | Colchicine 5件: Colchicine; Colchicine 1 mg oral tablet; Colchicine sprinkle capsules; Diagnostic test: colchicine level measurement; Other: colchicine cessation; | 1件: D00570 D00570 💬 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
002 7件: 2 , 42, 46, 56, 93, 210, 266 💬 |
102 | Corn | Corn 3件: Corn; Corn oil capsules; Corn/soy oil; | - |
- |
- |
046 2件: 46, 240 💬 |
103 | Corticotropin | Adrenocorticotropin hormone 8件: Adrenocorticotropin hormone; Corticotropin; Corticotropin-releasing hormone; H.p. acthar gel (repository corticotropin injection); Other: corticotropin releasing hormone (crh); Ovine corticotropin-releasing hormone (ocrh); Repository corticotropin injection; Repository corticotropin injection -treatment extension; | 1件: D00146 D00146 💬 |
1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 13件: 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬 |
104 | Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | - | - |
- |
- |
013 2件: 13, 46 💬 |
105 | CR6086 | Cr6086 2件: Cr6086; Cr6086z; | - |
- |
- |
046 1件: 46 💬 |
106 | Creatine | Creatine 4件: Creatine; Creatine monohydrate; Creatine-13c; Pyruvate, creatine, niacinamide; | - |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
107 | Creatinine | Creatinine 1件: Creatinine; | 1件: D03600 D03600 💬 |
- |
- |
002 4件: 2 , 46, 60, 70 💬 |
108 | CRx-139 | Crx-139 1件: Crx-139; | - |
- |
- |
046 1件: 46 💬 |
109 | Cultivated mushroom | - | - |
- |
- |
046 1件: 46 💬 |
110 | Curcumin | Bio-enhanced curcumin soft gelatin capsule 6件: Bio-enhanced curcumin soft gelatin capsule; Curcumin; Curcumin (longvida™); Curcumin supplement; Liposomed polyphenols resveratrol and curcumin; Nanocurcumin; | - |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
111 | Cyclophosphamide | Busulfan, cyclophosphamide, antithymocyte globulin 55件: Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Busulfan, cyclophosphamide, atg, gcsf; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Campath, fludarabine, cyclophosphamide; Cyclophosphamide; Cyclophosphamide (cy); Cyclophosphamide (cy) (plan 1); Cyclophosphamide (cy) (plan 2); Cyclophosphamide (cytoxan); Cyclophosphamide (drug); Cyclophosphamide + pred; Cyclophosphamide 100mg; Cyclophosphamide 150mg; Cyclophosphamide 30; Cyclophosphamide 40; Cyclophosphamide 50mg; Cyclophosphamide 50mg oral tablet; Cyclophosphamide and atg; Cyclophosphamide and fludarabine; Cyclophosphamide and steroids; Cyclophosphamide dose level 1; Cyclophosphamide dose level 2; Cyclophosphamide dose level 3; Cyclophosphamide dose level 4; Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids; Cyclophosphamide injection 1g; Cyclophosphamide monohydrate; Cyclophosphamide post transplant; Cyclophosphamide(ctx); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide, bortezomib, and dexamethasone (cybord); Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Cyclophosphamide, fludarabine; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Cyclophosphamide,campath ih and tbi; Cyclophosphamide,cyclosporine a; Cyclophosphamide-prednisone-azathioprine; Cyclophosphamide/glatiramer acetate; Fludarabine, cyclophosphamide; Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide''; High-dose cyclophosphamide; Iv cyclophosphamide; Lenalidomide, dexamethasone and cyclophosphamide; Prednisone and cyclophosphamide; Prednisone plus cyclophosphamide; Prednisone, cyclophosphamide; Prednisone, methylprednisolone,cyclophosphamides; Procedure: cyclophosphamide; Rituximab and cyclophosphamide iv; Thalidomide, cyclophosphamide and prednisone; | 2件: D00287 D00287
D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
112 | Cyclosporine | Atg+cyclosporine 26件: Atg+cyclosporine; Atg+rapamune+cyclosporine; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Cyclophosphamide,cyclosporine a; Cyclosporine; Cyclosporine (gengraf ); Cyclosporine (usan); Cyclosporine 5 mg/kg bid days 0-14; Cyclosporine a; Cyclosporine a (csa); Cyclosporine a dry powder inhalation (drug); Cyclosporine combine with mycophenolate mofetil; Cyclosporine inhalation solution; Cyclosporine inhalation solution (cis); Cyclosporine oral product; Cyclosporine pill; Cyclosporine vs infliximab; Cyclosporine-a; Device: cyclosporine a; Liposomal aerosol cyclosporine; Liposomal cyclosporine a; Liposomal cyclosporine a 10 mg; Liposomal cyclosporine a 5 mg; Oral cyclosporine; Rabbit atg, cyclosporine, levamisole; Twice-daily dosage with 0.5% cyclosporine-a eyedrops; | 1件: D00184 D00184 💬 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬 |
113 | Deferoxamine | Deferoxamine 2件: Deferoxamine; Deferoxamine mesilate; | 2件: D01186 D01186
D03670 D03670 💬 |
- |
- |
046 3件: 46, 284, 286 💬 |
114 | Delorazepam | - | 1件: D07784 D07784 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 3件: 6 , 46, 97 💬 |
115 | Denosumab | Denosumab 5件: Denosumab; Denosumab - - immunoglobulin g2 human monoclonal antibody to rank ligand; Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand; Pralia 60 mg subcutaneous injection syringe(denosumab); Pralia 60mg subcutaneous injection syringe(denosumab); | 1件: D03684 D03684 💬 |
1件: TNFSF11 💬 |
Breast cancer 7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 7件: 46, 50, 93, 95, 96, 274, 299 💬 |
116 | Dexamethasone | Bortezomib/dexamethasone 48件: Bortezomib/dexamethasone; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Bupivacaine/epinephrine/dexamethasone; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Control intervention (no dexamethasone); Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cyclophosphamide, bortezomib, and dexamethasone (cybord); Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Device: dexamethasone injection; Dexamethasone; Dexamethasone (1 cycle); Dexamethasone (4 cycles); Dexamethasone (50mg 1dd6, 3 consecutive days/month); Dexamethasone 0,1 mg tablets; Dexamethasone 0,5mg; Dexamethasone 0.5mg tablet; Dexamethasone 0.5mg/5ml solution; Dexamethasone 0.5mg/5ml solution in mucolox™; Dexamethasone 1,5 mg tablets; Dexamethasone 21-dihydrogen phosphate; Dexamethasone 21-phosphate; Dexamethasone 2mg tablets; Dexamethasone 4 mg jenapharm; Dexamethasone abcur; Dexamethasone and rituximab; Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland).; Dexamethasone parotid irrigation; Dexamethasone sodium phosphate; Dexamethasone sodium phosphate 250 mg/ 10 ml; Dexamethasone sodium phosphate 250 mg/10 ml solution; Dexamethasone sodium phosphate ph. eur.; Dexamethasone sodium sulfate; Dexamethasone soduim phosphate; Dexamethasone, 40 mg; Diagnostic test: dexamethasone test; High dose dexamethasone pulses; Intraarticular dexamethasone; Intravenous dexamethasone 1 mg; Lenalidomide and dexamethasone; Lenalidomide+dexamethasone; Lenalidomide, dexamethasone; Lenalidomide, dexamethasone and cyclophosphamide; Melphalan, thalidomide and dexamethasone; Mmf and dexamethasone; Peri-neural dexamethasone 1 mg; Pomalidomide and dexamethasone; Procedure: epidural steroid (dexamethasone) injection; | 9件: D00292 D00292
D00975 D00975
D01510 D01510
D01615 D01615
D01632 D01632
D01948 D01948
D02174 D02174
D02591 D02591
D02592 D02592 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
117 | Dexmedetomidine | Dexmedetomidine 10件: Dexmedetomidine; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine hydrochloride infusion; Dexmedetomidine with ropivacaine; Fentanyl (low dose) + dexmedetomidine; Scopolamine, atropine, edaravone and dexmedetomidine; | 2件: D00514 D00514
D01205 D01205 💬 |
3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 12件: 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
118 | Dextromethorphan | Dextromethorphan 10件: Dextromethorphan; Dextromethorphan 30 mg; Dextromethorphan and caffeine; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; | 3件: D00848 D00848
D03742 D03742
D03744 D03744 💬 |
6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
119 | Diacerein | Diacerein 2件: Diacerein; Diacerein 1% ointment; | 1件: D07270 D07270 💬 |
- |
- |
036 2件: 36, 46 💬 |
120 | Diazepam | Diazepam 2件: Diazepam; Diazepam, melatonin; | 1件: D00293 D00293 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
046 3件: 46, 155, 298 💬 |
121 | Diclofenac | Comparator: diclofenac 8件: Comparator: diclofenac; Comparator: diclofenac sodium; Diclofenac; Diclofenac + omeprazole; Diclofenac 50 milligrams; Diclofenac sodium; Diclofenac sodium topical gel; Diclofenac sr; | 3件: D00903 D00903
D00904 D00904
D07816 D07816 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 34, 46, 271 💬 |
122 | Digoxin | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 3件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Digoxin; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; | 1件: D00298 D00298 💬 |
4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 |
Adrenergic signaling in cardiomyocytes 18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
008 3件: 8 , 46, 210 💬 |
123 | Dipyridamole | Amoxapine & dipyridamole 8件: Amoxapine & dipyridamole; Dipyridamole; Dipyridamole and amoxapine; Dipyridamole tab 25 mg; Extended release dipyridamole 200mg/aspirin 25mg; Prednisolone & dipyridamole; Prednisolone-dipyridamole; Z102 (prednisolone and dipyridamole).; | 1件: D00302 D00302 💬 |
2件: PDE4A, PDE5A 💬 |
Metabolic pathways 6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 5件: 46, 49, 51, 66, 224 💬 |
124 | Doconexent | - | - |
- |
- |
006 10件: 6 , 46, 48, 49, 90, 94, 113, 240, 299, 301 💬 |
125 | Donepezil | Donepezil 7件: Donepezil; Donepezil hci (drug); Donepezil hydrochloride; Donepezil sandoz; Other: [11c]donepezil pet; Pridia (donepezil hydrochloride) 5mg; Prior donepezil 5mg; | 2件: D00670 D00670
D07869 D07869 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 9件: 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
126 | Doxycycline | Antimicrobial therapy: co-trimoxazole or doxycycline 10件: Antimicrobial therapy: co-trimoxazole or doxycycline; Doxycycline; Doxycycline 100 mg capsules; Doxycycline 100-200mg capsules daily for 6 months; Doxycycline hyclate; Doxycycline hyclate ph.eur; Doxycycline tablets; Interferon beta 1a, oral doxycycline; Other: no doxycycline; Treatment with systemic therapy (doxycycline); | 5件: D00307 D00307
D02129 D02129
D03903 D03903
D03904 D03904
D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
127 | Dronabinol | Cannabidiol / dronabinol capsule 5 mg+2,5 mg 5件: Cannabidiol / dronabinol capsule 5 mg+2,5 mg; Dronabinol; Dronabinol 25 mg/ml, oral drops; Dronabinol capsule 2,5 mg; Dronabinol capsule 2.5. mg; | 1件: D00306 D00306 💬 |
2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 7件: 2 , 8 , 13, 46, 96, 271, 298 💬 |
128 | Edoxaban | Edoxaban 1件: Edoxaban; | 2件: D09546 D09546
D09710 D09710 💬 |
1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
046 2件: 46, 88 💬 |
129 | Efalizumab | Efalizumab 1件: Efalizumab; | 1件: D03959 D03959 💬 |
1件: ITGAL 💬 |
Cell adhesion molecules 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
130 | Eldecalcitol | Eldecalcitol 1件: Eldecalcitol; | 1件: D07578 D07578 💬 |
1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 1件: 46 💬 |
131 | Enalapril | Enalapril 4件: Enalapril; Enalapril and other angiotensin converting enzyme inhibitors; Enalapril maleate; Enalapril valsartan methylprednisone; | 2件: D00621 D00621
D07892 D07892 💬 |
1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 66, 113, 210, 222, 223 💬 |
132 | Enoxaparin | Enoxaparin 1件: Enoxaparin; | 2件: D03674 D03674
D07510 D07510 💬 |
1件: SERPINC1 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
046 1件: 46 💬 |
133 | Entecavir | Entecavir 1件: Entecavir; | 2件: D04008 D04008
D07896 D07896 💬 |
- |
- |
046 5件: 46, 56, 96, 97, 271 💬 |
134 | Epinephrine | Bupivacaine/epinephrine/dexamethasone 4件: Bupivacaine/epinephrine/dexamethasone; Epinephrine; Lap tap bupivacaine/epinephrine; Us tap bupivacaine/epinephrine; | 3件: D00095 D00095
D00996 D00996
D02149 D02149 💬 |
9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 2件: 46, 96 💬 |
135 | Ergocalciferol | Ergocalciferol 3件: Ergocalciferol; Ergocalciferol (vitamin d2); Ergocalciferol 1.25 mg tablet; | 1件: D00187 D00187 💬 |
1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 5件: 46, 84, 96, 97, 299 💬 |
136 | Erythrityl tetranitrate | - | 1件: D04051 D04051 💬 |
2件: NPR1, NPR2 💬 |
Aldosterone synthesis and secretion 10件: Aldosterone synthesis and secretion, Metabolic pathways, Oxytocin signaling pathway, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
137 | Erythropoietin | Erythropoietin 4件: Erythropoietin; Erythropoietin human recombinant (eporh); Recombinant human erythropoietin; Recombinant human erythropoietin(rhepo); | 1件: D03231 D03231 💬 |
1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 10件: 2 , 6 , 13, 18, 22, 46, 47, 70, 95, 96 💬 |
138 | Esomeprazole | Esomeprazole 3件: Esomeprazole; Esomeprazole 20 mg; Nexium (esomeprazole magnesium); | 4件: D01984 D01984
D04056 D04056
D07917 D07917
D09339 D09339 💬 |
2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 6件: 13, 46, 86, 98, 298, 299 💬 |
139 | Estradiol | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream 9件: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream; Estradiol; Estradiol 2 mg; Estradiol hemihydrate; Ethinyl estradiol; Ethinylestradiol; Loestrin (norethindrone acetate and ethinyl estradiol); Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg; | 8件: D00105 D00105
D01413 D01413
D01617 D01617
D01953 D01953
D04061 D04061
D04063 D04063
D04064 D04064
D04065 D04065 💬 |
2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 5件: 13, 46, 49, 226, 299 💬 |
140 | Eszopiclone | Eszopiclone 1件: Eszopiclone; | 1件: D02624 D02624 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 3件: 6 , 13, 46 💬 |
141 | Etanercept | 50 mg etanercept 49件: 50 mg etanercept; Adalimuab, etanercept, tocilizumab, or abatacept; Adalimumab, etanercept, golimumab or infliximab; Anti-tnf therapy (etanercept or adalimumab); Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Commercial formulation etanercept; Enbrel (etanercept); Etanercept; Etanercept (50mg per week); Etanercept (50mg per week, for 2 weeks); Etanercept (50mg per week, for 4 weeks); Etanercept (enbrel); Etanercept (enbreltm); Etanercept (etn); Etanercept (full-dose); Etanercept (half-dose); Etanercept + methotrexate; Etanercept , methotrexate; Etanercept / autoinjector a; Etanercept 50 mg sc day 0 and day 3; Etanercept 50 mg/ml; Etanercept 50mg; Etanercept auto-injector; Etanercept biosimilar; Etanercept liquid; Etanercept optimal dosing; Etanercept or adalimumab; Etanercept pre-filled syringe; Etanercept pre-filled syringe sq injection; Etanercept treatment; Etanercept via autoinjector a; Etanercept via autoinjector b; Etanercept, methotrexate and depomedrone; Etanercept, methotrexate, prednisolone; Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), etc; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Lyophilized etanercept powder(yisaipu); Methotrexate - etanercept - prednisolone arm; New formulation etanercept; Phase 1: etanercept; Prefilled liquid etanercept(yisaipu); Procedure: intra-articular injection of etanercept; Reumatocept (etanercept); Sb4 (etanercept biosimilar); Sb4 (proposed biosimilar to etanercept); Tapering or discontinuation of etanercept; Tnf blockers (infliximab, adalimumab, etanercept); Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); | 1件: D00742 D00742 💬 |
2件: LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
015 15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬 |
142 | Ethinylestradiol | Ethinylestradiol 1件: Ethinylestradiol; | 1件: D00554 D00554 💬 |
1件: ESR1 💬 |
Breast cancer 8件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 4件: 13, 46, 49, 299 💬 |
143 | Etizolam | - | 1件: D01514 D01514 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
046 1件: 46 💬 |
144 | Etodolac | Etodolac 2件: Etodolac; Other non steroidal anti-inflammatory drugs (nsaids) except etodolac; | 1件: D00315 D00315 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
145 | Etoricoxib | Etoricoxib 8件: Etoricoxib; Etoricoxib 60 mg; Etoricoxib 90 mg; Mk0663, etoricoxib; Part i - etoricoxib 60 mg; Part i - etoricoxib 90 mg; Part ii- etoricoxib 60 mg; Part ii- etoricoxib 90 mg; | 1件: D03710 D03710 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 2件: 46, 271 💬 |
146 | Evobrutinib | Evobrutinib 4件: Evobrutinib; Evobrutinib 10mg; Evobrutinib 25mg; M2951 (other name: evobrutinib); | - |
- |
- |
013 3件: 13, 46, 49 💬 |
147 | Famotidine | Famotidine 2件: Famotidine; Famotidine 20 mg; | 1件: D00318 D00318 💬 |
1件: HRH2 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
006 4件: 6 , 46, 86, 98 💬 |
148 | Fentanyl | Fentanyl 8件: Fentanyl; Fentanyl (high dose); Fentanyl (low dose); Fentanyl (low dose) + dexmedetomidine; Fentanyl transdermal patch; Multi-modal pain management [fentanyl]; Standard analgesia use [fentanyl]; Transdermal fentanyl matrix, gabapentin; | 2件: D00320 D00320
D01399 D01399 💬 |
1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 4件: 46, 70, 215, 231 💬 |
149 | Ferrous sulfate anhydrous | - | - |
- |
- |
046 1件: 46 💬 |
150 | Filgotinib | Filgotinib 4件: Filgotinib; Inn - filgotinib; Proposed inn - filgotinib; Propsoed inn - filgotinib; | 1件: D10871 D10871 💬 |
1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 6件: 46, 53, 96, 97, 222, 271 💬 |
151 | Filgrastim | Ep2006 (filgrastim) 7件: Ep2006 (filgrastim); Filgrastim; Filgrastim (g-csf); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Pegfilgrastim; | 1件: D03235 D03235 💬 |
1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 33件: 2 , 6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
152 | Fish oil | Combination fish oil and borage seed oil 10件: Combination fish oil and borage seed oil; Combination of fish oil and colesevelam; Fish oil; Fish oil concentrate; Fish oil supplement; Fish oil, gamma-linolenic acid; Fish oil, rich in omega-3-acids; Fish oil,rich in omega 3 acids; Lipoic acid (la) with fish oil and la without fish oil; Omega-3 fatty acid fish oil supplement; | - |
- |
- |
013 7件: 13, 46, 49, 66, 96, 260, 299 💬 |
153 | Fletikumab | - | 1件: D11756 D11756 💬 |
1件: IL20 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
154 | Florasulam | - | - |
- |
- |
046 1件: 46 💬 |
155 | Fludarabine | Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen) 24件: Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Busulfan, fludarabine and atg; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Busulfan, fludarabine, atg, tli; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Campath, fludarabine, cyclophosphamide; Cyclophosphamide and fludarabine; Cyclophosphamide, fludarabine; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Fludarabine; Fludarabine (flu); Fludarabine monophosphate; Fludarabine phosphate; Fludarabine phosphate 30 mg; Fludarabine phosphate 40 mg; Fludarabine, busulfan, thymoglobulin; Fludarabine, cyclophosphamide; Fludarabine, melphalan, thiotepa; Fludarabine/ melphalan; Fludarabine/busulfan; Sq fludarabine; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; | 2件: D01907 D01907
D07966 D07966 💬 |
1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 18件: 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
156 | Fludeoxyglucose (18F) | - | - |
- |
- |
005 13件: 5 , 6 , 7 , 13, 34, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
157 | Flurbiprofen | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 3件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Flurbiprofen; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; | 3件: D00330 D00330
D01475 D01475
D02290 D02290 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 3件: 13, 21, 46 💬 |
158 | Flutriciclamide F-18 | - | - |
- |
- |
046 1件: 46 💬 |
159 | Folic acid | Folic acid 5件: Folic acid; Folic acid or folate; Folic acid, vitamin b6, vitamin b12; Methotrexate and folic acid; Rituximab, mtx, folic acid; | 1件: D00070 D00070 💬 |
- |
- |
006 5件: 6 , 13, 46, 49, 84 💬 |
160 | Fontolizumab | Fontolizumab 1件: Fontolizumab; | 1件: D04242 D04242 💬 |
1件: IFNG 💬 |
African trypanosomiasis 32件: African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
046 1件: 46 💬 |
161 | Fostamatinib | Fostamatinib 12件: Fostamatinib; Fostamatinib 100 mg; Fostamatinib 100 mg tablet; Fostamatinib 150 mg; Fostamatinib 150 mg bid; Fostamatinib 150 mg tablet; Fostamatinib 50 mg blue film-coated tablet; Fostamatinib disodium; Fostamatinib disodium (r935788); Fostamatinib disodium tablet 100 mg; Fostamatinib disodium tablet 150 mg; R788, fostamatinib disodium hexahydrate (in uspi/fpi); | 1件: D09347 D09347 💬 |
1件: SYK 💬 |
B cell receptor signaling pathway 17件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 4件: 46, 49, 61, 66 💬 |
162 | Gadobutrol | Gadobutrol 2件: Gadobutrol; Other: gadobutrol; | 1件: D07420 D07420 💬 |
- |
- |
013 3件: 13, 22, 46 💬 |
163 | Gadolinium | Device: magnetic resonance imaging (mri) with gadolinium enhancement 10件: Device: magnetic resonance imaging (mri) with gadolinium enhancement; Device: magnetic resonance imaging (mri) without gadolinium enhancement; Diagnostic test: cardiac mri (gadolinium enhanced); Gadolinium; Gadolinium contrast; Gadolinium for abdomen; Gadolinium for lower back; Gadolinium-based contrast; Other: uspio mri - gadolinium mri; Standard gadolinium contrast; | - |
- |
- |
013 6件: 13, 34, 46, 58, 65, 86 💬 |
164 | Gamolenic acid | - | 1件: D07213 D07213 💬 |
- |
- |
013 3件: 13, 19, 46 💬 |
165 | Ginger | Ginger 1件: Ginger; | 1件: D06744 D06744 💬 |
- |
- |
046 1件: 46 💬 |
166 | Ginseng | American ginseng 4件: American ginseng; American ginseng extract ht-1001; Ginseng; Korean red ginseng; | 1件: D06772 D06772 💬 |
- |
- |
013 3件: 13, 46, 53 💬 |
167 | Ginsenosides | - | - |
- |
- |
046 1件: 46 💬 |
168 | GLPG-0259 | Glpg0259 3件: Glpg0259; Glpg0259 (part b); Glpg0259 oral capsule; | - |
- |
- |
046 1件: 46 💬 |
169 | Glucosamine | Device: technetium labelled glucosamine 2件: Device: technetium labelled glucosamine; Glucosamine; | 1件: D04334 D04334 💬 |
- |
- |
046 2件: 46, 271 💬 |
170 | Gold | Gold 7件: Gold; Gold nanocrystals; Mtx goldshield tablets; Other: comparator: cpet cycle ergometer (gold standard); Procedure: quantiferon-tb gold assay; Procedure: repair of cdh w/sis gold; Sodium aurothiomalate (intramuscular gold); | - |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
171 | Golimumab | Adalimumab, etanercept, golimumab or infliximab 45件: Adalimumab, etanercept, golimumab or infliximab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Diagnostic test: antibodies to golimumab; Diagnostic test: golimumab trough levels; Exposure to golimumab; Golimumab; Golimumab (cnto 148); Golimumab (glm); Golimumab (gol); Golimumab (optimization); Golimumab 1 mg per kg; Golimumab 100 mg; Golimumab 100 mg injections; Golimumab 2 mg per kg; Golimumab 2 mg/kg iv; Golimumab 200 mg; Golimumab 4 mg per kg; Golimumab 400 mg; Golimumab 50 mg; Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg; Golimumab 50 mg injections; Golimumab 50 mg sc; Golimumab dose 1; Golimumab dose 2; Golimumab final vialed product (fvp); Golimumab injection; Golimumab intravenous; Golimumab intravenous (iv); Golimumab liquid in prefilled pen; Golimumab liquid in prefilled pen or prefilled syringe; Golimumab liquid in prefilled syringe; Golimumab liquid in vial; Golimumab pre-filled syringe; Golimumab prefilled pen; Golimumab prefilled pen or prefilled syringe; Golimumab prefilled syringe; Golimumab treatment optimization.; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Iv golimumab; Prefilled syringe delivery of golimumab; Sc golimumab; Simponi (golimumab); Simponi® (golimumab); Smartject device delivery of golimumab; Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); | 1件: D04358 D04358 💬 |
1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 6件: 46, 56, 84, 96, 97, 271 💬 |
172 | Grapefruit | Grapefruit 2件: Grapefruit; Grapefruit juice; | - |
- |
- |
006 5件: 6 , 46, 50, 83, 97 💬 |
173 | Green tea leaf | Green tea leaf 1件: Green tea leaf; | 1件: D06903 D06903 💬 |
- |
- |
006 5件: 6 , 17, 28, 46, 96 💬 |
174 | GS-5745 | Gs-5745 3件: Gs-5745; Gs-5745 iv; Gs-5745 sc; | - |
- |
- |
046 4件: 46, 96, 97, 299 💬 |
175 | GSK-3117391 | Gsk3117391 1件: Gsk3117391; | - |
- |
- |
046 1件: 46 💬 |
176 | GW-274150 | Gw274150 2件: Gw274150; Gw274150 tablets; | - |
- |
- |
046 1件: 46 💬 |
177 | GW-406381 | Gw406381 2件: Gw406381; Gw406381x; | - |
- |
- |
046 1件: 46 💬 |
178 | Haemagglutinin-strain B | - | - |
- |
- |
021 4件: 21, 46, 49, 50 💬 |
179 | HE3286 | He3286 1件: He3286; | - |
- |
- |
046 2件: 46, 97 💬 |
180 | Hepatitis A Vaccine | Epaxal berna (virosomal hepatitis a vaccine) 4件: Epaxal berna (virosomal hepatitis a vaccine); Hepatitis a vaccine; Hepatitis a vaccine ( havrix or epaxal); Hepatitis a vaccine and tetanus vaccine; | - |
- |
- |
046 3件: 46, 96, 97 💬 |
181 | Hepatitis B Vaccine (Recombinant) | - | - |
- |
- |
046 2件: 46, 50 💬 |
182 | Human interleukin-2 | Anti-human interleukin-23 monoclonal antibody 3件: Anti-human interleukin-23 monoclonal antibody; Human interleukin-2; Recombinant human interleukin-2 (rhil-2); | - |
- |
- |
002 17件: 2 , 13, 35, 46, 49, 51, 53, 55, 56, 60, 63, 65, 95, 96, 97, 162, 271 💬 |
183 | Human Umbilical Cord Mesenchymal Stem Cells | Human umbilical cord mesenchymal stem cells 1件: Human umbilical cord mesenchymal stem cells; | - |
- |
- |
002 12件: 2 , 13, 36, 46, 49, 51, 60, 96, 97, 113, 274, 284 💬 |
184 | Hyaluronic acid | Hyaluronic acid 5件: Hyaluronic acid; Hyaluronic acid and chondroitin sulfate; Hyaluronic acid inhalation solution; Hyaluronic acid/chondroitin sulfate; Standard care hyaluronic acid eye drops; | 1件: D08043 D08043 💬 |
- |
- |
046 7件: 46, 53, 70, 97, 226, 231, 299 💬 |
185 | Hydrocortisone | 90 mg hydrocortisone acetate suppository with sephure suppository applicator 31件: 90 mg hydrocortisone acetate suppository with sephure suppository applicator; Combination oral budesonide and rectal hydrocortisone; Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortef (hydrocortisone); Dual release hydrocortisone (plenadren); Hydrocortisone; Hydrocortisone (solucortef); Hydrocortisone 100mg/ml; Hydrocortisone 10mg; Hydrocortisone 10mg tablet; Hydrocortisone 10mg tablets; Hydrocortisone 20mg tablets; Hydrocortisone acetate; Hydrocortisone cream; Hydrocortisone cream 1%; Hydrocortisone cream 10mg/g fna fagron; Hydrocortisone hydrogen succinate; Hydrocortisone modified release capsules; Hydrocortisone roussel; Hydrocortisone sodium acetate; Hydrocortisone sodium phosphate; Hydrocortisone sodium succinate; Hydrocortisone tablet 2.5 mg; Hydrocortisone takeda, tabletter; Mesalazine with hydrocortisone sodium succinate; Other: hydrocortisone; Procedure: hydrocortisone withdrawal; Solu-cortef (hydrocortisone); Subcutaneous hydrocortisone; Subcutaneous hydrocortisone 10mg; | 1件: D00088 D00088 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
006 9件: 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
186 | Hydroxide ion | - | - |
- |
- |
046 4件: 46, 96, 97, 284 💬 |
187 | Hydroxychloroquine | Hydroxychloroquine 19件: Hydroxychloroquine; Hydroxychloroquine (z0188); Hydroxychloroquine + prednisone; Hydroxychloroquine high; Hydroxychloroquine higher dose; Hydroxychloroquine lower dose; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Hydroxychloroquine sulfate; Hydroxychloroquine sulphate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Other: hydroxychloroquine/chloroquine; Plaquenil - hydroxychloroquine 200mg film coated tablets; Sirolimus and hydroxychloroquine 200 mg; Sirolimus and hydroxychloroquine 400 mg; Sulphasalazine + hydroxychloroquine or prednisolone; Versus hydroxychloroquine; | 1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
188 | HZT-501 | Hzt-501 1件: Hzt-501; | - |
- |
- |
046 1件: 46 💬 |
189 | Ibandronate | Ibandronate 2件: Ibandronate; Ibandronate+alfacalcidol+calcium; | 1件: D08056 D08056 💬 |
1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 3件: 46, 49, 274 💬 |
190 | Ibuprofen | Ibuprofen 6件: Ibuprofen; Ibuprofen 200mg; Ibuprofen sandoz 400 mg filmtabletten; Other: ibuprofen and isosorbide dinitrate combination; Rebif new formulation + ibuprofen prn; Rebif new formulation + prophylactic ibuprofen; | 4件: D00126 D00126
D01122 D01122
D04490 D04490
D06606 D06606 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 6件: 13, 46, 65, 113, 271, 299 💬 |
191 | Icosapent | Eicosapentaenoic acid 4件: Eicosapentaenoic acid; Ethyl icosapent; Ethyl-icosapent; Icosapent; | 1件: D08061 D08061 💬 |
- |
- |
008 10件: 8 , 46, 48, 49, 96, 97, 113, 296, 297, 301 💬 |
192 | Iguratimod | Iguratimod 2件: Iguratimod; Iguratimod (careram); | 1件: D01146 D01146 💬 |
1件: NFKB1 💬 |
AGE-RAGE signaling pathway in diabetic complications 72件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway |
046 4件: 46, 51, 53, 271 💬 |
193 | Imatinib | Bevacizumab (avastin) and imatinib mesylate (gleevec) 7件: Bevacizumab (avastin) and imatinib mesylate (gleevec); Imatinib; Imatinib mesilate; Imatinib mesilato; Imatinib mesylate; Imatinib mesylate (gleevec); Imatinib mesylate 400mg capsule; | 2件: D01441 D01441
D08066 D08066 💬 |
3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
194 | Indocyanine green | Indocyanine green 3件: Indocyanine green; Indocyanine green(icg); Verde de indocianina (indocyanine green); | 1件: D01342 D01342 💬 |
- |
- |
046 7件: 46, 51, 96, 235, 278, 291, 296 💬 |
195 | Indopan | - | - |
- |
- |
046 2件: 46, 97 💬 |
196 | Infliximab | 99m technetium infliximab 70件: 99m technetium infliximab; 99mtc-infliximab; Abp 710 - biosimilar to infliximab; Adalimumab and infliximab; Adalimumab, etanercept, golimumab or infliximab; Anti tnf therapy including infliximab; Anti-tnf: infliximab (infusion); Azathioprine or adalimumab and infliximab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Biosimilar infliximab; Ct-p13 sc (infliximab); Cyclosporine vs infliximab; Inflectra (infliximab); Infliximab; Infliximab (bcd-055); Infliximab (ifx alone); Infliximab (ifx); Infliximab (inf) + mtx, db; Infliximab (remicade); Infliximab (remicade): 100 mg of lyophilized infliximab; Infliximab + methotrexate (mtx); Infliximab 10 mg/kg; Infliximab 20 mg/kg; Infliximab 3 mg/kg; Infliximab 5 mg/kg; Infliximab 5 mg/kg body weight infused over 2 hours; Infliximab 5 mg/kg every 6 weeks; Infliximab 7 mg/kg every 8 weeks; Infliximab [infliximab biosimilar 3]; Infliximab and adalimumab; Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab and mtx; Infliximab biosimilar; Infliximab control; Infliximab group; Infliximab increased dose; Infliximab increased frequency; Infliximab infusion; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, adalimumab, certolizumab pegol; Infliximab, azathioprine; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Infliximab, methylprednisolone, methotrexate; Infliximab-biosimilar; Infliximab-eu; Infliximab-innovator; Infliximab-pfizer; Innovator infliximab; Intravitreal infliximab; Methotrexate + infliximab; Other: infliximab (ifx) infusion; Other: measurement of drug (adalimumab/infliximab); Procedure: measurement of serum infliximab and anti-infliximab antibodies; Procedure: treatment according to current standards without knowledge of serum infliximab and anti-infliximab ab status; Remicade (infliximab); Remicade® (infliximab); Remicaide (infliximab); Remsima (infliximab); Response to infliximab associated with methotrexate; Sb2 (infliximab biosimilar); Sb2 (proposed biosimilar to infliximab); Ta-650 (infliximab); Tnf blockers (infliximab, adalimumab, etanercept); Topical infliximab; Trexan+salazopyrin+oxiklorin+prednisolone + infliximab; Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); | 1件: D02598 D02598 💬 |
1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
197 | Interleukin-1 alpha, human recombinant | - | - |
- |
- |
046 11件: 46, 65, 84, 85, 96, 97, 140, 161, 231, 271, 299 💬 |
198 | Interleukin-10 | Guna-interleukin 10 2件: Guna-interleukin 10; Interleukin 10; | - |
- |
- |
046 1件: 46 💬 |
199 | Iodine | Iodine 2件: Iodine; Radiation: computed tomography lung subtraction iodine mapping; | 1件: D00108 D00108 💬 |
- |
- |
028 3件: 28, 46, 88 💬 |
200 | ISIS 104838 | Isis 104838 1件: Isis 104838; | - |
- |
- |
046 1件: 46 💬 |
201 | Isoxaflutole | - | - |
- |
- |
005 9件: 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
202 | Itacitinib | Itacitinib 2件: Itacitinib; Itacitinib adipate; | 1件: D10944 D10944 💬 |
1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 5件: 46, 51, 60, 97, 228 💬 |
203 | JNJ-40346527 | Jnj-40346527 5件: Jnj-40346527; Jnj-40346527-aac; Jnj-40346527-aac - capsule - 50 mg; Prv-6527 (jnj-40346527); Prv-6527(jnj-40346527); | - |
- |
- |
046 2件: 46, 96 💬 |
204 | KC706 | Kc706 1件: Kc706; | - |
- |
- |
035 2件: 35, 46 💬 |
205 | Ketoprofen | Ketoprofen 1件: Ketoprofen; | 1件: D00132 D00132 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
206 | keyhole limpet hemocyanin | Keyhole limpet hemocyanin 3件: Keyhole limpet hemocyanin; Keyhole limpet hemocyanin (klh); Keyhole limpet hemocyanin (klh) neo-antigen; | - |
- |
- |
013 2件: 13, 46 💬 |
207 | Lacosamide | Lacosamide 1件: Lacosamide; | 1件: D07299 D07299 💬 |
2件: SCN3A, SCN9A 💬 |
Taste transduction 1件: Taste transduction |
002 3件: 2 , 46, 149 💬 |
208 | Lamivudine | Abacavir sulfate, lamivudine and zidovudine 7件: Abacavir sulfate, lamivudine and zidovudine; Combivir (zidovudine [azt] / lamivudine [3tc]); Lamivudine; Lamivudine/zidovudine; Lopinavir/ritonavir + zidovudine + lamivudine; Reverse transcriptase inhibitors: zidovudine, lamivudine, abacavir; Zidovudine/lamivudine; | 1件: D00353 D00353 💬 |
- |
- |
026 6件: 26, 42, 46, 135, 265, 325 💬 |
209 | Leflunomide | Leflunomide 10件: Leflunomide; Leflunomide (permitted, not necessary); Leflunomide 10 milligram (mg); Leflunomide 10mg tab; Leflunomide 20 mg tablets (geneva pharmaceutical); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Leflunomide 20mg tab; Leflunomide mylan; Leflunomide(lef); Leflunomide-sulfasalazine-hydroxychloroquine; | 1件: D00749 D00749 💬 |
1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
011 10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬 |
210 | Leucovorin | Leucovorin 2件: Leucovorin; Methotrexate, leucovorin and bms-986142; | 3件: D01211 D01211
D07986 D07986
D07987 D07987 💬 |
- |
- |
019 2件: 19, 46 💬 |
211 | Levobupivacaine | Levobupivacaine 1件: Levobupivacaine; | 2件: D01287 D01287
D08116 D08116 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 1件: 46 💬 |
212 | Levofloxacin | Levofloxacin 4件: Levofloxacin; Levofloxacin hemihydrate; Levofloxacin kabi; Mp-376 (levofloxacin solution for inhalation); | 2件: D00588 D00588
D08120 D08120 💬 |
- |
- |
046 5件: 46, 53, 84, 85, 299 💬 |
213 | Lidocaine | 5% lidocaine/5 mg/ml 0.02% estradiol compound cream 11件: 5% lidocaine/5 mg/ml 0.02% estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Heparin & alkalinized lidocaine bladder instillation; Lidocaine; Lidocaine 1% injectable solution; Lidocaine 2% without vessel constrictor; Lidocaine injection 2%; Lidocaine patch 5%; Lidocaine releasing intravesical system - liris®; Local anesthesia (lidocaine hydrochloride); | 3件: D00358 D00358
D02086 D02086
D08127 D08127 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 12件: 6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬 |
214 | Lisinopril | Coenzyme q10 and lisinopril 4件: Coenzyme q10 and lisinopril; Lisinopril; Lisinopril pills; Lisinopril, losartan, and atorvastatin; | 2件: D00362 D00362
D08131 D08131 💬 |
1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 49, 66, 67, 113, 222 💬 |
215 | Loratadine | Loratadine 1件: Loratadine; | 1件: D00364 D00364 💬 |
1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 3件: 13, 46, 98 💬 |
216 | Losartan | Lisinopril, losartan, and atorvastatin 12件: Lisinopril, losartan, and atorvastatin; Losartan; Losartan and atenolol or propranolol; Losartan and nebivolol; Losartan and other angiotensin receptor blockers; Losartan bluefish 50 mg; Losartan hexal; Losartan potasico; Losartan potassium; Losartan tablets & qingremoshen granule; Other: losartan; Sildenafil and losartan; | 2件: D00357 D00357
D08146 D08146 💬 |
1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
217 | Lovastatin | Lovastatin 5件: Lovastatin; Lovastatin 60 mg; Lovastatin ™; Lovastatin, then minocycline/lovastatin; Minocycline, then minocycline/lovastatin; | 1件: D00359 D00359 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬 |
218 | Loxoprofen | Loxoprofen 3件: Loxoprofen; Loxoprofen sodium hydrogel patch; Loxoprofen sodium tablet; | 1件: D08149 D08149 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 2件: 46, 271 💬 |
219 | Lumiracoxib | Lumiracoxib 1件: Lumiracoxib; | 1件: D03714 D03714 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
220 | Magnesium | (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide 19件: (s)-4,5-dihydro-2-[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; (s)-4,5-dihydro-2[hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiazolecarboxylate magnesium hydroxide; Magnesium; Magnesium aspartate; Magnesium aspartate hydrochloride; Magnesium citrate; Magnesium gluconate; Magnesium hydroxide; Magnesium oxide; Magnesium sulfate; Magnesium with ropivacaine; Mineral boost (magnesium); Nexium (esomeprazole magnesium); Omeprazole magnesium; Saroglitazar magnesium 2 mg; Saroglitazar magnesium 4 mg; Sodium picosulfate, magnesium oxide and citric acid; Sodium picosulfate/magnesium citrate laxative; Sulfate, magnesium; | - |
- |
- |
006 17件: 6 , 11, 13, 46, 51, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
221 | Maraviroc | All subjects will receive maraviroc 300mg orally twice a day for 6 weeks 2件: All subjects will receive maraviroc 300mg orally twice a day for 6 weeks; Maraviroc; | 1件: D06670 D06670 💬 |
1件: CCR5 💬 |
Chemokine signaling pathway 9件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor |
046 2件: 46, 84 💬 |
222 | Masitinib | Masitinib 12件: Masitinib; Masitinib (3.0); Masitinib (4.5); Masitinib (6.0); Masitinib (ab1010); Masitinib 100 mg tablets; Masitinib 100mg; Masitinib 200 mg tablets; Masitinib 200mg; Masitinib 3 mg; Masitinib 6.0 mg; Masitinib mesylate; | 1件: D10229 D10229 💬 |
1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
223 | Mavrilimumab | Combination product: mavrilimumab 7件: Combination product: mavrilimumab; Mavrilimumab; Mavrilimumab 10 mg; Mavrilimumab 100 mg; Mavrilimumab 150 mg; Mavrilimumab 30 mg; Mavrilimumab 50 mg; | 1件: D09930 D09930 💬 |
1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
041 2件: 41, 46 💬 |
224 | MC-1 | Diagnostic test: 11c-mc1 2件: Diagnostic test: 11c-mc1; Mc1; | - |
- |
- |
046 1件: 46 💬 |
225 | Medical Cannabis | - | - |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
226 | Mefloquine | (+) erythromefloquine 5件: (+) erythromefloquine; (+) isomer of racemic mefloquine; (+) isomer or racemic mefloquine; (+)erythromefloquine; Mefloquine; | 1件: D04895 D04895 💬 |
- |
- |
025 2件: 25, 46 💬 |
227 | Melatonin | 3 mg melatonin 11件: 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin; Melatonin cr; Melatonin pr; Melatonin(circadin®); Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.; | 1件: D08170 D08170 💬 |
2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
228 | Meloxicam | Aspirin and meloxicam 8件: Aspirin and meloxicam; Meloxicam; Meloxicam 0.125 mg/kg; Meloxicam 0.25 mg/kg; Meloxicam ampoule; Meloxicam oral suspension; Meloxicam suppository; Meloxicam tablet; | 1件: D00969 D00969 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 4件: 46, 49, 271, 296 💬 |
229 | Mesalazine | 1500mg mesalazine pellets 35件: 1500mg mesalazine pellets; 250mg mesalazine pellets; 500mg mesalazine pellets; 750mg mesalazine pellets; Azathioprine or mesalazine; Delayed and extended release mesalazine; Mesalazine; Mesalazine (3,600 mg); Mesalazine (asacol®); Mesalazine (mesalamine); Mesalazine - tid 1000 mg; Mesalazine - tid 2x 500 mg; Mesalazine 1000 mg gastro-resistant tablets; Mesalazine 250mg; Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet; Mesalazine 4g enema; Mesalazine 500 mg gastro-resistant tablets (salofa; Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg); Mesalazine ec 500 mg; Mesalazine enema; Mesalazine liquid enema; Mesalazine slow-release granules; Mesalazine sustained-release tablets; Mesalazine tablet; Mesalazine tablets; Mesalazine with hydrocortisone sodium succinate; Mesalazine, tripterygium glycosides; Mmx mesalamine/ mesalazine; Mmx mesalamine/mesalazine; Mmx mesalamine/mesalazine (high dose); Mmx mesalamine/mesalazine (low dose); Other: mesalazine; Overencapsulated mesalazine tablets; Spd476 (mesalazine); Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine; | 1件: D00377 D00377 💬 |
- |
- |
046 4件: 46, 96, 97, 164 💬 |
230 | Mestranol | - | 1件: D00575 D00575 💬 |
2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 2件: 46, 49 💬 |
231 | Metformin | 750 mg metformin and 7.5 g l-citrulline daily p.o. 21件: 750 mg metformin and 7.5 g l-citrulline daily p.o.; Glucophage (metformin); L-citrulline and metformin & l-citrulline; Metformin; Metformin (generic); Metformin 500mg; Metformin and metformin & l-citrulline; Metformin hcl; Metformin hydrochloride; Metformin treatment; Metformin/cp-690,550; Metformina; Metformina - 500 30 compresse 500 mg; Metformine; Metformine arrow 500mg; Metformine hcl 500 pch; Metformine sandoz 850 mg filmomhulde tabletten; Other: metformin; Pioglitazone or metformin; Sitagliptin and metformin; [metformina]; | 2件: D00944 D00944
D04966 D04966 💬 |
2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
232 | Methamidophos | - | - |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
233 | Methotrexate | Abatacept (aba) + methotrexate (mtx), double-blind (db) 113件: Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept + methotrexate; Adalimumab with methotrexate; Azathioprine or methotrexate; Bms-582949 and methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Certolizumab pegol + methotrexate (mtx); Clobetasol propionate + methotrexate; Combination product: methotrexate; Cp-690,550 + methotrexate; Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids; Cyclosporin, methotrexate (gvhd prophylaxis); Dmards (methotrexate; Early immunosuppressants (azathioprine, methotrexate); Etanercept + methotrexate; Etanercept , methotrexate; Etanercept, methotrexate and depomedrone; Etanercept, methotrexate, prednisolone; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Infliximab + methotrexate (mtx); Infliximab, methylprednisolone, methotrexate; Intrathecal methotrexate; Methotrexate; Methotrexate 'lederle' 2,5mg tablets; Methotrexate 'lederle' 2.5mg tablets; Methotrexate 'lederle' tablets; Methotrexate (metoject® prefilled pen); Methotrexate (mtx); Methotrexate (stable dose); Methotrexate (tapering dose); Methotrexate + biologic administration; Methotrexate + infliximab; Methotrexate + methylprednisolone; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate - amneal; Methotrexate - dava; Methotrexate - delay; Methotrexate - etanercept - prednisolone arm; Methotrexate - immediate; Methotrexate 10 mg; Methotrexate 10 mg tablets; Methotrexate 2.5 mg; Methotrexate 2.5 mg tablets; Methotrexate 2.5mg tablets; Methotrexate 2.5mg tablets bp; Methotrexate 25 mg; Methotrexate 50mg/ml solution for injection, pre-filled syringe; Methotrexate ``lederle`` 2.5mg tablets; Methotrexate and folic acid; Methotrexate as methotrexate disodium; Methotrexate bellon; Methotrexate bellon 25mg/ml; Methotrexate capsules; Methotrexate disodium; Methotrexate ebewe; Methotrexate hospira 2,5 mg tablety; Methotrexate hospira 2.5 mg tablety; Methotrexate injection; Methotrexate lachema 5inj. sol; Methotrexate lederle 2.5 mg tablets; Methotrexate pfizer 2,5 mg tabletter; Methotrexate placebo; Methotrexate plus enbrel or enbrel alone; Methotrexate plus erb-041 for 12 weeks; Methotrexate plus sulfasalazine; Methotrexate pre-filled pen; Methotrexate prefilled pen; Methotrexate prefilled syringe; Methotrexate sodium; Methotrexate sodium 2.5mg tablets; Methotrexate sodium tablets 2.5 mg; Methotrexate sodium tablets 2.5mg; Methotrexate tablets; Methotrexate tablets 2.5 mg; Methotrexate treatment; Methotrexate wyeth 2,5mg; Methotrexate wyeth 2,5mg tbl.; Methotrexate ® 2.5mg tablets; Methotrexate(mtx); Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol; Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.; Methotrexate(necessary); Methotrexate*100cpr 2,5mg; Methotrexate*10mg/1,33ml 4s; Methotrexate*15mg/2ml 4sir; Methotrexate*2,5mg 25cpr; Methotrexate*20mg/2,66ml 4s; Methotrexate*25cpr 2,5mg; Methotrexate*7,5mg/ml 4sir.; Methotrexate, leucovorin and bms-986142; Methotrexate,adalimumab; Methotrexate-lachema; Methotrexate-sulfasalazine-hydroxychloroquine; Methotrexate® 2.5 mg tablets; Mp-435(dose1) + methotrexate; Mycophenolate mofetil,methotrexate; Oral methotrexate; Other: methotrexate therapy; Phase 1: methotrexate; Response to anakinra associated with methotrexate; Response to infliximab associated with methotrexate; Stable weekly dose of methotrexate; Tacrolimus with methotrexate; Tak-715 and methotrexate; Tak-783 and methotrexate; Tasocitinib plus methotrexate; Tocilizumab + methotrexate(mtx); Tocilizumab plus methotrexate; Tocilizumab+methotrexate(mtx); Tofacitinib with methotrexate; Tofacitinib without methotrexate; Treatment with systemic therapy (methotrexate); Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level; | 2件: D00142 D00142
D02115 D02115 💬 |
2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
234 | Methoxsalen | Methoxsalen 2件: Methoxsalen; Methoxsalen +ecp; | 1件: D00139 D00139 💬 |
- |
- |
036 3件: 36, 46, 96 💬 |
235 | Methylprednisolone | Administration of rituximab and methylprednisolone 35件: Administration of rituximab and methylprednisolone; Corticosteroid treatment (methylprednisolone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Infliximab, methylprednisolone, methotrexate; Interferon-beta-1a (avonex) plus methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Intravenous methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methotrexate + methylprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone (mp); Methylprednisolone (mp) or prednisone (pred); Methylprednisolone (or other glucocorticoid); Methylprednisolone (solu-medrol); Methylprednisolone 1250 mg/24h x3 days; Methylprednisolone acetate; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone mylan générique; Methylprednisolone or budesonide; Methylprednisolone or prednisolone; Methylprednisolone po; Methylprednisolone pulse; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Oral methylprednisolone 625 mg/24h x3 days; Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; | 6件: D00407 D00407
D00751 D00751
D00979 D00979
D05000 D05000
D05001 D05001
D05002 D05002 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
236 | Methylprednisone | Enalapril valsartan methylprednisone 2件: Enalapril valsartan methylprednisone; Methylprednisone; | - |
- |
- |
046 3件: 46, 66, 222 💬 |
237 | Metronidazole | 10% metronidazole ointment 6件: 10% metronidazole ointment; Amoxicillin, metronidazole and tetracycline; Azithromycin + metronidazole; Metronidazole; Metronidazole capsule 50 mg; Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication); | 3件: D00409 D00409
D05016 D05016
D05017 D05017 💬 |
- |
- |
046 8件: 46, 51, 63, 94, 95, 96, 97, 291 💬 |
238 | Midazolam | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 7件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Midazolam; Midazolam 2 mg; Midazolam 3 mg; Midazolam injection; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; | 3件: D00550 D00550
D00696 D00696
D05028 D05028 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
239 | Milnacipran | Milnacipran 1件: Milnacipran; | 1件: D08222 D08222 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
046 2件: 46, 49 💬 |
240 | Minocycline | Combination of minocycline and mtx or mtx alone 8件: Combination of minocycline and mtx or mtx alone; Glatiramer acetate with minocycline; Lovastatin, then minocycline/lovastatin; Minocycline; Minocycline 100 mg film-coated tablets; Minocycline 100mg; Minocycline hydrochloride; Minocycline, then minocycline/lovastatin; | 2件: D00850 D00850
D05045 D05045 💬 |
- |
- |
002 14件: 2 , 6 , 8 , 13, 46, 84, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
241 | Minodronic acid | Minodronic acid 1件: Minodronic acid; | - |
- |
- |
006 4件: 6 , 46, 93, 95 💬 |
242 | Misoprostol | Misoprostol 1件: Misoprostol; | 1件: D00419 D00419 💬 |
3件: PTGER2, PTGER3, PTGER4 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway |
046 3件: 46, 70, 271 💬 |
243 | Mizoribine | Mizoribine 1件: Mizoribine; | 1件: D01392 D01392 💬 |
2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
046 8件: 46, 49, 51, 53, 66, 94, 222, 224 💬 |
244 | MK-0812 | Mk0812 2件: Mk0812; Mk0812 / duration of treatment: 12 weeks; | - |
- |
- |
013 2件: 13, 46 💬 |
245 | MK-0873 | Mk-0873 1件: Mk-0873; | - |
- |
- |
046 1件: 46 💬 |
246 | MM-093 | Mm-093 1件: Mm-093; | - |
- |
- |
046 1件: 46 💬 |
247 | Montelukast | 5 mg montelukast 8件: 5 mg montelukast; Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Montelukast; Montelukast sodium; Montelukast teva; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; Montelukast/ singulair; Singulair (montelukast sodium); | 2件: D00529 D00529
D08229 D08229 💬 |
1件: CYSLTR1 💬 |
Calcium signaling pathway 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
013 5件: 13, 46, 85, 98, 228 💬 |
248 | Morphine | Intraarticular morphine 7件: Intraarticular morphine; Morphine; Morphine hexal; Morphine hydrochloride; Morphine pca; Morphine sulfate; Morphine sulphate in intrasite gel; | 3件: D00842 D00842
D02271 D02271
D08233 D08233 💬 |
1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 5件: 36, 46, 70, 85, 86 💬 |
249 | Moxifloxacin | Avelox- moxifloxacin 6件: Avelox- moxifloxacin; Moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride; Moxifloxacin infusion; Moxifloxacina cloridrato; | 2件: D00874 D00874
D08237 D08237 💬 |
- |
- |
002 8件: 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
250 | Naltrexone | 4.5 mg naltrexone 6件: 4.5 mg naltrexone; Low dose naltrexone; Low-dose naltrexone; Naltrexone; Naltrexone hydrochloride; Naltrexone-hcl; | 2件: D02095 D02095
D05113 D05113 💬 |
3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 13件: 6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬 |
251 | Namilumab | Namilumab 2件: Namilumab; Namilumab (mt203); | - |
- |
- |
046 1件: 46 💬 |
252 | Naproxen | Comparator: naproxen tablet 500 mg 11件: Comparator: naproxen tablet 500 mg; Naproxen; Naproxen (ec-narosyn) delayed release tables, 375 (syntex (usa), inc.); Naproxen 10 mg/kg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Naproxen delayed release tables, 375 (gevena pharmaceuticals, inc.); Naproxen oral suspension; Naproxen sodium 550mg tablet; Part i- naproxen 1000 mg; Part ii- naproxen 1000 mg; Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); | 1件: D00118 D00118 💬 |
2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 3件: 13, 46, 271 💬 |
253 | Natalizumab | Bg00002 (natalizumab) 19件: Bg00002 (natalizumab); Bg00002-e (natalizumab high titer); Bg0002 (natalizumab); Dosing interruption of natalizumab; Natalizumab; Natalizumab (bg00002); Natalizumab (ntz); Natalizumab (tysabri); Natalizumab for iv infusion; Natalizumab for subcutaneous injection; Natalizumab injection [tysabri]; Natalizumab iv; Natalizumab sc; Natalizumab treatment; Other: natalizumab; Other: natalizumab discontinuation; Personalized extended interval dosing of natalizumab; Tysabri ® (natalizumab); Tysabri® (natalizumab); | 1件: D06886 D06886 💬 |
1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 6件: 13, 15, 25, 46, 63, 96 💬 |
254 | Nesiritide | - | 1件: D05147 D05147 💬 |
1件: NPR1 💬 |
Aldosterone synthesis and secretion 10件: Aldosterone synthesis and secretion, Metabolic pathways, Oxytocin signaling pathway, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 2件: 46, 58 💬 |
255 | Niclosamide | Niclosamide 1件: Niclosamide; | 1件: D00436 D00436 💬 |
- |
- |
046 2件: 46, 97 💬 |
256 | Nimesulide | Nimesulide 1件: Nimesulide; | 1件: D01049 D01049 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
257 | Nitric Oxide | Inhaled nitric oxide 14件: Inhaled nitric oxide; Inhaled nitric oxide & inopulse delivery; Inhaled nitric oxide - 30 mcg/kg ibw/hr; Inhaled nitric oxide 5,10,15 mcg/kg ibw/hr; Inhaled nitric oxide 75 mcg/kg ibw/hr; Nitric oxide; Nitric oxide 160 ppm; Nitric oxide for inhalation; Nitric oxide generated by the geno nitrosyl delivery system; Nitric oxide plus oxygen; Nitric oxide supplement; Other: oral nitric oxide testing; Procedure: exhaled nitric oxide; Procedure: exhaled nitric oxide assessment; | 1件: D00074 D00074 💬 |
- |
- |
046 8件: 46, 85, 86, 98, 210, 251, 294, 299 💬 |
258 | Nitroglycerin | 10% nitroglycerine in propylene glycol, usp 8件: 10% nitroglycerine in propylene glycol, usp; Nitroglycerin; Nitroglycerin ointment 2%; Nitroglycerine; Nitroglycerine gel; Sublingual nitroglycerine; Topical amphimatrix with nitroglycerin (mqx-503); Topical organogel with nitroglycerin; | 1件: D00515 D00515 💬 |
- |
- |
046 2件: 46, 51 💬 |
259 | Nivolumab | Nivolumab 1件: Nivolumab; | 1件: D10316 D10316 💬 |
1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
260 | Norethisterone | - | 2件: D00182 D00182
D00953 D00953 💬 |
1件: PGR 💬 |
Breast cancer 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 4件: 13, 46, 49, 299 💬 |
261 | Ocrelizumab | Ocrelizumab 15件: Ocrelizumab; Ocrelizumab / rhumab 2h7; Ocrelizumab 300 mg; Ocrelizumab 300mg; Ocrelizumab 300mg /10ml; Ocrelizumab 300mg/10 ml; Ocrelizumab 300mg/10ml; Ocrelizumab 500mg; Ocrelizumab 600 mg; Ocrelizumab at home; Ocrelizumab dose 1; Ocrelizumab dose 2 and dose 3; Ocrelizumabu 200mg; Ocrelizumabu 50mg; Other: observation of ocrelizumab as treatment in rrms patients; | 1件: D05218 D05218 💬 |
1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 3件: 13, 46, 49 💬 |
262 | Ofatumumab | Combination product: ofatumumab with ai 10件: Combination product: ofatumumab with ai; Combination product: ofatumumab with prf; Ofatumumab; Ofatumumab 100; Ofatumumab 300; Ofatumumab 30mg; Ofatumumab 3mg; Ofatumumab 60mg; Ofatumumab 700; Ofatumumab subcutaneous injection; | 1件: D09314 D09314 💬 |
1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 3件: 13, 35, 46 💬 |
263 | Olokizumab | Olokizumab 11件: Olokizumab; Olokizumab (okz); Olokizumab 120 mg; Olokizumab 240 mg; Olokizumab 60 mg; Olokizumab 64 mg sc q2w; Olokizumab 64 mg sc q4w; Olokizumab 64mg q2w; Olokizumab 64mg q4w; Olokizumab q2w; Olokizumab q4w; | - |
- |
- |
046 2件: 46, 96 💬 |
264 | Omalizumab | Omalizumab 4件: Omalizumab; Omalizumab (xolair); Recombinant humanized monoclonal antibody omalizumab to ige; Rituximab combined with omalizumab; | 1件: D05251 D05251 💬 |
1件: FCER1A 💬 |
Asthma 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
046 7件: 46, 53, 65, 98, 162, 226, 299 💬 |
265 | Omega-3 fatty acids | Lipoic acid and omega-3 fatty acids 3件: Lipoic acid and omega-3 fatty acids; Omega-3 fatty acids; Triomar™ (omega-3 fatty acids); | - |
- |
- |
013 7件: 13, 46, 49, 66, 79, 96, 299 💬 |
266 | Omeprazole | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) 19件: Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Clartihromycin, amoxicillin, and omeprazole; Diclofenac + omeprazole; Dimebon + omeprazole; Esomeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Nexium (esomeprazole magnesium); Omeprazole; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 20mg; Omeprazole 20mg bid; Omeprazole 40 mg; Omeprazole 40mg capsule; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Rifaximin+omeprazole+miralax; | 4件: D00455 D00455
D01207 D01207
D05259 D05259
D05261 D05261 💬 |
2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
267 | Otelixizumab | Otelixizumab 1件: Otelixizumab; | 1件: D08959 D08959 💬 |
3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
046 1件: 46 💬 |
268 | Otilimab | Otilimab 2件: Otilimab; Otilimab (gsk3196165); | 1件: D11343 D11343 💬 |
1件: CSF2 💬 |
Acute myeloid leukemia 16件: Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
269 | OTL-38 | Otl38 1件: Otl38; | - |
- |
- |
046 1件: 46 💬 |
270 | Oxycodone | Extended-release oxycodone 17件: Extended-release oxycodone; Oxycodone; Oxycodone by patient-controlled analgesia (pca); Oxycodone depot ”sandoz”, depot tablets; Oxycodone hydrochloride; Oxycodone naloxone prolonged release tablets; Oxycodone orion; Oxycodone/acetaminophen; Oxycodone/naloxone prolonged release t; Oxycodone/naloxone prolonged release tablets; Oxycodone/naloxone prolonged release tablets 10 mg /5 mg; Oxycodone/naloxone prolonged release tablets 10/5 mg; Oxycodone/naloxone prolonged release tablets 20 mg /10 mg; Oxycodone/naloxone prolonged release tablets 20/10 mg; Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg; Oxycodone/naloxone prolonged release tablets 5/2.5 mg; Pr oxycodone; | 3件: D03783 D03783
D05312 D05312
D05462 D05462 💬 |
3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 7件: 6 , 13, 46, 70, 226, 231, 298 💬 |
271 | Oxygen | Behavioral: respiratory and exercise therapy with supplemental oxygen 39件: Behavioral: respiratory and exercise therapy with supplemental oxygen; Combination product: hyperbaric oxygen therapy-; Continuous oxygen; Device: auto-titrating oxygen system; Device: capacity of muscular oxygen extraction; Device: high flow nasal oxygen cannula; Device: hyperbaric oxygen; Device: intermittent exposure to oxygen via oro-nasal mask; Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation; Device: oxygen; Device: oxygen saturation; Device: standard oxygen therapy/ra; Diagnostic test: maximum oxygen uptake; Helium / oxygen mixed gas inhalation therapy; Medical air vs oxygen; Medical grade oxygen; Nitric oxide plus oxygen; Other: 60% oxygen; Other: air - oxygen; Other: hyperbaric oxygen; Other: hyperbaric oxygen therapy; Other: muscle oxygenation; Other: optional blood-oxygen-level dependent functionalmri; Other: oxygen; Other: oxygen (2liter/min); Other: oxygen (4liter/min); Other: oxygen - air; Other: oxygen supplementation; Oxygen; Oxygen 40 %; Oxygen supplementation; Oxygen, liquid; Perfluorinated gas/oxygen mixture; Procedure: hyperbaric oxygen; Procedure: hyperbaric oxygen therapy; Procedure: long term oxygen therapy; Procedure: oxygen flow at the optic nerve head measurement; Procedure: supplemental oxygen via a mask; Standard analgesia use [oxygen]; | 1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
272 | Ozoralizumab | Ozoralizumab 1件: Ozoralizumab; | 1件: D09944 D09944 💬 |
1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
273 | Paclitaxel | Micellar paclitaxel for injection 2件: Micellar paclitaxel for injection; Paclitaxel; | 2件: D00491 D00491
D05333 D05333 💬 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
046 2件: 46, 85 💬 |
274 | Panax quinquefolius whole | - | - |
- |
- |
013 2件: 13, 46 💬 |
275 | Parecoxib | Parecoxib 1件: Parecoxib; | 2件: D02709 D02709
D03716 D03716 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 2件: 46, 271 💬 |
276 | Paroxetine | Paroxetine 4件: Paroxetine; Paroxetine & prednisolone; Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp; Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp; | 4件: D02260 D02260
D02362 D02362
D05374 D05374
D05375 D05375 💬 |
1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 3件: 6 , 13, 46 💬 |
277 | Pateclizumab | - | 1件: D10187 D10187 💬 |
1件: LTA 💬 |
Cytokine-cytokine receptor interaction 7件: Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
278 | Peficitinib | Peficitinib 1件: Peficitinib; | 1件: D10653 D10653 💬 |
3件: JAK1, JAK2, JAK3 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 1件: 46 💬 |
279 | Pegsunercept | Pegsunercept 2件: Pegsunercept; Pegsunercept (peg stnf-ri); | 1件: D05393 D05393 💬 |
1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
280 | Pelubiprofen | Pelubiprofen 2件: Pelubiprofen; Pelubiprofen 30 mg; | 1件: D01865 D01865 💬 |
- |
- |
046 1件: 46 💬 |
281 | Pertussis vaccine | Pertussis vaccine 2件: Pertussis vaccine; Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed); | 1件: D06514 D06514 💬 |
- |
- |
046 1件: 46 💬 |
282 | PF-06650833 | Pf-06650833 3件: Pf-06650833; Pf-06650833 100 mg; Pf-06650833 20 mg; | - |
- |
- |
046 1件: 46 💬 |
283 | PF-06651600 | Pf-06651600 4件: Pf-06651600; Pf-06651600 10 mg; Pf-06651600 50 mg; Pf-06651600-15; | - |
- |
- |
046 3件: 46, 96, 97 💬 |
284 | PH-797804 | Ph-797804 1件: Ph-797804; | - |
- |
- |
046 1件: 46 💬 |
285 | Phosphate ion | - | - |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
286 | Phosphatidyl serine | - | 1件: D04682 D04682 💬 |
- |
- |
046 3件: 46, 90, 97 💬 |
287 | Phylloquinone | Phylloquinone 2件: Phylloquinone; Phylloquinone (vitamin k1); | 1件: D00148 D00148 💬 |
- |
- |
013 6件: 13, 46, 96, 97, 288, 299 💬 |
288 | Piclidenoson | Piclidenoson 1件: Piclidenoson; | 1件: D10971 D10971 💬 |
1件: ADORA3 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
289 | Pidolic acid | - | - |
- |
- |
046 2件: 46, 70 💬 |
290 | Pioglitazone | Actos (pioglitazone) 6件: Actos (pioglitazone); Pioglitazone; Pioglitazone 15 mg; Pioglitazone and tretinoin; Pioglitazone or metformin; Tretinoin and pioglitazone hcl; | 2件: D00945 D00945
D08378 D08378 💬 |
1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
291 | Pirfenidone | Pirfenidone 7件: Pirfenidone; Pirfenidone (pfd); Pirfenidone 267 mg [esbriet]; Pirfenidone and nintedanib; Pirfenidone or nintedanib; Pirfenidoneone; Sub-study: pirfenidone; | 1件: D01583 D01583 💬 |
6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
292 | Polyethylene glycol | 2l polyethylene glycol/ascorbic acid 6件: 2l polyethylene glycol/ascorbic acid; C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker; Polyethylene glycol; Polyethylene glycol 3350; Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker; Treatment with polyethylene glycol (macrogol 4000); | 1件: D03370 D03370 💬 |
- |
- |
006 11件: 6 , 13, 46, 65, 78, 96, 97, 235, 240, 276, 299 💬 |
293 | Potassium | Dipotassium salt 5件: Dipotassium salt; Losartan potassium; Potassium; Potassium sparing diuretic; Potassium supplement; | 1件: D08403 D08403 💬 |
- |
- |
036 10件: 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
294 | Pravastatin | Lonafarnib, zoledronic acid, and pravastatin 5件: Lonafarnib, zoledronic acid, and pravastatin; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; Pravastatin; Pravastatin sodium; Zoledronic acid, pravastatin; | 2件: D00893 D00893
D08410 D08410 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
295 | Prednisolone | Administration of rituximab and methylprednisolone 96件: Administration of rituximab and methylprednisolone; Azd4017 and prednisolone; Combination therapy with vigabatrin and prednisolone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Corticosteroid (prednisolone); Corticosteroid treatment (methylprednisolone or prednisolone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Etanercept, methotrexate, prednisolone; Glucocorticoid (prednisone or prednisolone); Infliximab, methylprednisolone, methotrexate; Interferon-beta-1a (avonex) plus methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Intravenous methyl prednisolone; Intravenous methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Lodotra (delayed release prednisolone); Long-circulating liposomal prednisolone; Low dose prednisolone; Medium dose prednisolone; Megadose oral methylprednisolone; Methotrexate + methylprednisolone; Methotrexate - etanercept - prednisolone arm; Methyl prednisolone; Methyloprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone (mp); Methylprednisolone (mp) or prednisone (pred); Methylprednisolone (or other glucocorticoid); Methylprednisolone (solu-medrol); Methylprednisolone 1250 mg/24h x3 days; Methylprednisolone acetate; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone mylan générique; Methylprednisolone or budesonide; Methylprednisolone or prednisolone; Methylprednisolone po; Methylprednisolone pulse; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Metilprednisolone; Metilprednisolone sodio succinato; Méthylprednisolone; Méthylprednisolone mylan; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Oral methylprednisolone 625 mg/24h x3 days; Oral prednisolone; Overencapsulated prednisolone tablets; Paroxetine & prednisolone; Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp; Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp; Peg-liposomal prednisolone sodium phosphate; Prednisolone; Prednisolone & dipyridamole; Prednisolone + mabthera; Prednisolone 1mg tablets; Prednisolone 2,5 mg tablets; Prednisolone 20 mg; Prednisolone 40 mg; Prednisolone 5 mg; Prednisolone 5 mg jenapharm; Prednisolone 5 mg tablets; Prednisolone 5mg gastro-resistant tablets; Prednisolone 5mg tablet; Prednisolone acetate; Prednisolone and chlorambucil; Prednisolone and mycophenolate mofetil; Prednisolone and taper; Prednisolone labesfal; Prednisolone sodium metasulphobenzoate; Prednisolone sodium phosphate; Prednisolone sodium succinate; Prednisolone tablets b.p. 5mg; Prednisolone tablets bp; Prednisolone tablets bp 1 mg; Prednisolone tablets usp 5 mg; Prednisolone-dipyridamole; Prednisolone/prednisone; Prednisone (and methylprednisolone); Prednisone or prednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone/prednisolone; Pyridoxine plus prednisolone; Soluble prednisolone tablets; Sulphasalazine + hydroxychloroquine or prednisolone; Trexan+salazopyrin+oxiklorin+prednisolone; Trexan+salazopyrin+oxiklorin+prednisolone + infliximab; Z102 (prednisolone and dipyridamole).; [metilprednisolone sodio succinato]; [metilprednisolone]; | 8件: D00472 D00472
D00980 D00980
D00981 D00981
D00982 D00982
D01239 D01239
D01998 D01998
D02156 D02156
D03301 D03301 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
296 | Prednisone | 0 mg prednisone 73件: 0 mg prednisone; 5 mg prednisone; 5-aminosalicylic acid(5-asa) and/or prednisone; Adalimumab, plus prednisone; Azathioprine/prednisone; Chinese herb prescription granule plus prednisone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Cyclophosphamide-prednisone-azathioprine; Enalapril valsartan methylprednisone; Glucocorticoid (prednisone or prednisolone); Granulocyte-colony stimulating factor (g-csf) and prednisone; Hormone (prednisone); Hydroxychloroquine + prednisone; Ir prednisone; Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Methylprednisone; Mr prednisone; Mycophenolate mofetil plus lower dose of prednisone; Oral prednisone; Oral prednisone 5mg; Other: prednisone; Over encapsulated prednisone; Prednisolone/prednisone; Prednisone; Prednisone (and methylprednisolone); Prednisone + inhibace/cozaar; Prednisone - azathioprine; Prednisone 0,5 mg/kg orally on alternate days; Prednisone 1 mg; Prednisone 15 mg; Prednisone 2 mg; Prednisone 3 mg; Prednisone 4 mg; Prednisone 5 mg; Prednisone 5 mg tablets; Prednisone 7.5 mg; Prednisone acetate; Prednisone acetate tablets; Prednisone alone; Prednisone and belimumab; Prednisone and cyclophosphamide; Prednisone and mycophenolate mofetil; Prednisone and ustekinumab treatment; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone capsules; Prednisone discontinuation; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Prednisone, ciclosporin and mycophenolate mofetil; Prednisone, cyclophosphamide; Prednisone, fk506, mmf; Prednisone, low dose rituximab; Prednisone, methylprednisolone,cyclophosphamides; Prednisone/prednisolone; Procedure: thymectomy plus prednisone; Rayos (delayed-release prednisone); Sotatercept with prednisone boost; Tacrolimus combined with prednisone; Thalidomide, cyclophosphamide and prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Ursodeoxycholic acid+low dose glucocorticoid(prednisone); | 1件: D00473 D00473 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
297 | Pregabalin | Antioxidant plus pregabalin 3件: Antioxidant plus pregabalin; Pregabalin; Pregabalin 75mg; | 1件: D02716 D02716 💬 |
4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 5件: 13, 36, 46, 70, 298 💬 |
298 | Propofol | Device: propofol dosage 5件: Device: propofol dosage; Intubated with propofol (ip); Procedure: sedation with iv propofol; Propofol; Propofol-lipuro; | 1件: D00549 D00549 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 9件: 6 , 21, 22, 34, 46, 75, 84, 98, 296 💬 |
299 | Puerarin | Puerarin 3件: Puerarin; Puerarin injection 400 mg; Puerarin tablet 50 mg; | - |
- |
- |
046 1件: 46 💬 |
300 | Pyrazole | (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide 2件: (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide; Pyrazole; | - |
- |
- |
028 4件: 28, 46, 58, 75 💬 |
301 | Pyrimethamine | Fansidar (pyrimethamine and sulfadoxine) 2件: Fansidar (pyrimethamine and sulfadoxine); Pyrimethamine; | 1件: D00488 D00488 💬 |
- |
- |
002 10件: 2 , 4 , 6 , 19, 46, 51, 65, 96, 97, 265 💬 |
302 | Raloxifene | Raloxifene 2件: Raloxifene; Raloxifene hydrochloride; | 2件: D02217 D02217
D08465 D08465 💬 |
2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
046 1件: 46 💬 |
303 | Ramelteon | Ramelteon 1件: Ramelteon; | 1件: D02689 D02689 💬 |
2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
006 3件: 6 , 8 , 46 💬 |
304 | Ramipril | Ramipril 1件: Ramipril; | 1件: D00421 D00421 💬 |
1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 7件: 46, 49, 66, 67, 113, 218, 257 💬 |
305 | Rebamipide | Nanoparticulated rebamipide 3件: Nanoparticulated rebamipide; Other: autologous serum and rebamipide 2%; Rebamipide; | 1件: D01121 D01121 💬 |
- |
- |
046 4件: 46, 53, 97, 271 💬 |
306 | Rehmannia glutinosa root | - | - |
- |
- |
046 2件: 46, 76 💬 |
307 | Revamilast | Revamilast 1件: Revamilast; | - |
- |
- |
046 1件: 46 💬 |
308 | Riboflavin | Cofactor supplementation (thiamine, riboflavin, l-carnitine) 4件: Cofactor supplementation (thiamine, riboflavin, l-carnitine); Riboflavin; Riboflavin sodium phosphate injection; Riboflavin supplementation; | 3件: D00050 D00050
D01622 D01622
D01913 D01913 💬 |
- |
- |
013 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬 |
309 | Rifampicin | Rifampicin 1件: Rifampicin; | 1件: D00211 D00211 💬 |
- |
- |
006 8件: 6 , 13, 17, 46, 84, 86, 93, 299 💬 |
310 | Rimacalib | Rimacalib 1件: Rimacalib; | - |
- |
- |
046 1件: 46 💬 |
311 | Risedronic acid | Risedronic acid 1件: Risedronic acid; | 3件: D00942 D00942
D03234 D03234
D08484 D08484 💬 |
1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 8件: 46, 50, 66, 93, 95, 96, 113, 274 💬 |
312 | Rituximab | Abatacept, rituximab or tocilizumab 67件: Abatacept, rituximab or tocilizumab; Abp 798 - biosimilar to rituximab; Abp 798 biosimilar to rituximab; Administration of rituximab and methylprednisolone; Alemtuzumab and rituximab; Alemtuzumab, rituximab; Bendamustine, rituximab; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Combined plasma exchange (pex), rituximab, and corticosteroids; Dexamethasone and rituximab; Double-blind rituximab; Dr. reddy’s rituximab (drl_ri) 100mg; Dr. reddy’s rituximab (drl_ri) 500mg; Eltrombopag combining rituximab; Etanercepet, rituximab, abatacept, tocilizumab, sarilumab; Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab); Gp2013 - a proposed biosimilar rituximab; Idec-c2b8 (rituximab); Immunosuppressive treatment (eg, rituximab); Individualized dose of rituximab; Intravenous rituximab; Mabthera (rituximab); Mabthera or biosimilar rituximab product; Mabthera® (rituximab); Originator rituximab - rituxan ® or mabthera ®; Prednisone, low dose rituximab; Rhtpo in combination with rituximab; Rituxan (inn: rituximab), brand name in the united states; Rituxan (inn: rituximab), brand name in the us; Rituxan (rituximab); Rituxan® (rituximab); Rituximab; Rituximab (anti-cd20); Rituximab (arm a); Rituximab (arm b); Rituximab (eu); Rituximab (genetical recombination); Rituximab (mabthera® or rituxan®).; Rituximab (mabthera®); Rituximab (rituxan); Rituximab (rtx) and azathioprine (aza); Rituximab (us); Rituximab - mabthera; Rituximab 1g iv; Rituximab [mabthera/rituxan]; Rituximab [mabthera]; Rituximab and cyclophosphamide iv; Rituximab combined with omalizumab; Rituximab infusion; Rituximab it; Rituximab iv; Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml; Rituximab mabthera; Rituximab or rituximab hyaluronidase human; Rituximab, mabthera; Rituximab, mtx, folic acid; Rituximab, observational study amon patients with active ra; Rituximab-eu+ rituximab-pfizer x 2 courses; Rituximab-pfizer; Rituximab-pfizer (pf-05280586) x 3 courses; Rituximab-us + rituximab-pfizer x 2 courses; Rituximab/ mabthera; Sait101 (proposed rituximab biosimilar); Sait101 (rituximab biosimilar); Standard dose of rituximab; The standard steroid treatment, plasma exchange and rituximab; [rituximab]; | 1件: D02994 D02994 💬 |
1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
313 | Rivaroxaban | Lmwh/rivaroxaban 3件: Lmwh/rivaroxaban; Rivaroxaban; Rivaroxaban 20 mg; | 1件: D07086 D07086 💬 |
1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
046 5件: 46, 49, 75, 91, 210 💬 |
314 | Rofecoxib | Rofecoxib 1件: Rofecoxib; | 1件: D00568 D00568 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
315 | Romosozumab | Romosozumab 1件: Romosozumab; | 1件: D10156 D10156 💬 |
1件: SOST 💬 |
Parathyroid hormone synthesis, secretion and action 2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway |
046 2件: 46, 274 💬 |
316 | Ropivacaine | Dexmedetomidine with ropivacaine 5件: Dexmedetomidine with ropivacaine; Magnesium with ropivacaine; Ropivacaine; Ropivacaine plus normal saline; Tramadol with ropivacaine; | 2件: D04048 D04048
D08490 D08490 💬 |
5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
036 3件: 36, 46, 70 💬 |
317 | Rosiglitazone | Recombinant human growth hormone + rosiglitazone 6件: Recombinant human growth hormone + rosiglitazone; Rosiglitazone; Rosiglitazone (avandia); Rosiglitazone extended release tablets; Rosiglitazone maleate; Rosiglitazone xr; | 2件: D00596 D00596
D08491 D08491 💬 |
1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 5件: 46, 75, 97, 222, 265 💬 |
318 | Rosuvastatin | Calcium rosuvastatin 8件: Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Rosuvastatin; Rosuvastatin 10 mg; Rosuvastatin 20mg; Rosuvastatin calcium; Rosuvastatin calcium 40mg; Rosuvastatine eg; | 2件: D01915 D01915
D08492 D08492 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
319 | Roxithromycin | Roxithromycin 1件: Roxithromycin; | 1件: D01710 D01710 💬 |
- |
- |
046 2件: 46, 299 💬 |
320 | Rupatadine | Rupatadine 1件: Rupatadine; | 1件: D07407 D07407 💬 |
2件: HRH1, PTAFR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
046 1件: 46 💬 |
321 | Sarilumab | Etanercepet, rituximab, abatacept, tocilizumab, sarilumab 6件: Etanercepet, rituximab, abatacept, tocilizumab, sarilumab; Sarilumab; Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara]; Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara]_#1; Sarilumab sar153191; Sarilumab sar153191 (regn88); | 1件: D10161 D10161 💬 |
1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
041 5件: 41, 46, 84, 107, 271 💬 |
322 | SC12267 | Sc12267 2件: Sc12267; Sc12267 (4sc-101); | - |
- |
- |
046 3件: 46, 96, 97 💬 |
323 | Secukinumab | 150 mg double-blinded secukinumab 16件: 150 mg double-blinded secukinumab; 150 mg open-label secukinumab; 300 mg double-blinded secukinumab; Secukinumab; Secukinumab (150 mg); Secukinumab (75 mg); Secukinumab (ain457); Secukinumab (ain457) 150 mg s.c.; Secukinumab 150 mg (2 injections per dose; Secukinumab 150 mg provided in 1.0 ml pre-filled syringes (pfss) for sc injection.; Secukinumab 150 mg/1 ml solution for injection; Secukinumab 150 milligram [cosentyx]; Secukinumab 150mg; Secukinumab 300 mg, s.c.; Secukinumab 300mg; Secukinumab 75 mg/0.5 ml solution for injection; | 1件: D09967 D09967 💬 |
1件: IL17A 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
013 7件: 13, 37, 41, 46, 160, 269, 271 💬 |
324 | Sildenafil | 20 mg sildenafil citrate by mouth 32件: 20 mg sildenafil citrate by mouth; 5% sildenafil cream; Access program - sildenafil citrate, viagra, revatio; Bosentan and sildenafil; Duo-therapy with sildenafil + bosentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); G04be03- sildenafil - sildenafil (citrato); Mono-therapy with sildenafil; Oral sildenafil; Other: standard of care sildenafil; Sildenafil; Sildenafil (50 mg); Sildenafil (acute-1 hour); Sildenafil (as citrate); Sildenafil (revatio); Sildenafil (revatio) 20 mg tid; Sildenafil (subchronic-4 weeks); Sildenafil 20 mg tablets; Sildenafil 20mg; Sildenafil 20mg and bosentan 62.5mg; Sildenafil 40mg oral capsule; Sildenafil and losartan; Sildenafil by injection; Sildenafil citrate; Sildenafil citrate (uk-92,480); Sildenafil filmtabletten; Sildenafil singly or in association with bosentan; Sildenafil therapy; Sildenafilo; Sitaxsentan and sildenafil; Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth; Tadalafil and sildenafil; | 2件: D02229 D02229
D08514 D08514 💬 |
1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
325 | Simvastatin | Encapsulated simvastatin tablets 21件: Encapsulated simvastatin tablets; Ezetimibe+simvastatin drug combination; Other: simvastatin; Simvastatin; Simvastatin 20 mg; Simvastatin 20mg/5ml oral suspension; Simvastatin 40 mg; Simvastatin 40 mg film-coated tablets; Simvastatin 40 mg tablets; Simvastatin 40mg; Simvastatin alternova; Simvastatin in relapsing remitting multiple sclerosis; Simvastatin susp.; Simvastatin treatment for 28 days; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; | 1件: D00434 D00434 💬 |
1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 21件: 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
326 | Sirolimus | Rapamycin, sirolimus 22件: Rapamycin, sirolimus; Sirolimus; Sirolimus (formerly known as rapamycin); Sirolimus (study drug)+ace inhibitor + statin; Sirolimus 0,1% crème; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 1mg/ml; Sirolimus 2 mg; Sirolimus 2%; Sirolimus and hydroxychloroquine 200 mg; Sirolimus and hydroxychloroquine 400 mg; Sirolimus ointment; Sirolimus oral liquid product 1mg/ml; Sirolimus oral product; Sirolimus, 2%; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Tavt-18 (sirolimus); Temsirolimus; Temsirolimus tablets; Topical 0.1% sirolimus; | 1件: D00753 D00753 💬 |
1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 40件: 2 , 6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
327 | Sirukumab | Sirukumab 3件: Sirukumab; Sirukumab 100 mg; Sirukumab 50 mg; | 1件: D10080 D10080 💬 |
1件: IL6 💬 |
AGE-RAGE signaling pathway in diabetic complications 49件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection |
041 2件: 41, 46 💬 |
328 | Sodium aurothiomalate | Sodium aurothiomalate 2件: Sodium aurothiomalate; Sodium aurothiomalate (intramuscular gold); | 1件: D00992 D00992 💬 |
- |
- |
046 1件: 46 💬 |
329 | Sodium chloride | 0.9% sodium chloride 24件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); 0.9% sodium chloride injection; 0.9% w/v isotonic sodium chloride solution; 0.9% w/v sodium chloride solution; Isotonic sodium chloride solution; Other: 0.9% sodium chloride; Other: 0.9ml sodium chloride; Other: sodium chloride; Physiological serum (sodium chloride); Procedure: 9% sodium chloride (nacl) iv; Sodium chloride; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 0.9%; Sodium chloride 6%; Sodium chloride 7%; Sodium chloride ph. eur.; Sodium chloride solution; Sodium chloride solution 0.9%; Sodium chloride solvent; Sodium pyruvate in 0.9% sodium chloride solution; Solucion de cloruro de sodio sodium chloride solution; Solvente cloruro de sodio sodium chloride solvent; | 1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
330 | Somatotropin | Recombinant human somatotropin 3件: Recombinant human somatotropin; Somatotropin; Somatotropine; | 1件: D02691 D02691 💬 |
1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 20件: 2 , 3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬 |
331 | Streptococcus pneumoniae type 1 capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
332 | Streptococcus pneumoniae type 10a capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
333 | Streptococcus pneumoniae type 11a capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
334 | Streptococcus pneumoniae type 12f capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
335 | Streptococcus pneumoniae type 14 capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
336 | Streptococcus pneumoniae type 15b capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
337 | Streptococcus pneumoniae type 17f capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
338 | Streptococcus pneumoniae type 18c capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
339 | Streptococcus pneumoniae type 19a capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
340 | Streptococcus pneumoniae type 19f capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
341 | Streptococcus pneumoniae type 2 capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
342 | Streptococcus pneumoniae type 20 capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
343 | Streptococcus pneumoniae type 22f capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
344 | Streptococcus pneumoniae type 23f capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
345 | Streptococcus pneumoniae type 3 capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
346 | Streptococcus pneumoniae type 33f capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
347 | Streptococcus pneumoniae type 4 capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
348 | Streptococcus pneumoniae type 5 capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
349 | Streptococcus pneumoniae type 6b capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
350 | Streptococcus pneumoniae type 7f capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
351 | Streptococcus pneumoniae type 8 capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
352 | Streptococcus pneumoniae type 9n capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
353 | Streptococcus pneumoniae type 9v capsular polysaccharide antigen | - | - |
- |
- |
046 2件: 46, 50 💬 |
354 | Sulfasalazine | Leflunomide-sulfasalazine-hydroxychloroquine 6件: Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate plus sulfasalazine; Methotrexate-sulfasalazine-hydroxychloroquine; Nsaids and sulfasalazine; Sulfasalazine; Sulfasalazine, ssz; | 1件: D00448 D00448 💬 |
- |
- |
046 4件: 46, 86, 94, 271 💬 |
355 | Sulfate ion | - | - |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
356 | Sulpiride | - | 2件: D01226 D01226
D08549 D08549 💬 |
1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 5件: 2 , 6 , 17, 46, 70 💬 |
357 | Sunflower oil | High oleic sunflower oil 2件: High oleic sunflower oil; Sunflower oil; | 1件: D09006 D09006 💬 |
- |
- |
046 3件: 46, 240, 299 💬 |
358 | Tabalumab | Ly2127399 (tabalumab) 4件: Ly2127399 (tabalumab); Tabalumab; Tabalumab auto-injector; Tabalumab prefilled syringe; | 1件: D10083 D10083 💬 |
1件: TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
046 2件: 46, 49 💬 |
359 | Tacrine | - | 2件: D02068 D02068
D08555 D08555 💬 |
1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
046 3件: 46, 271, 299 💬 |
360 | Tacrolimus | Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf 17件: Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Interferon beta-1b and tacrolimus; Lcp-tacro (tacrolimus); Rectal tacrolimus; Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil); Tacrolimus; Tacrolimus (advagraf); Tacrolimus (prograf®); Tacrolimus (tacro); Tacrolimus and mmf; Tacrolimus capsule; Tacrolimus capsule (low-dose); Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus prolonged-release hard capsules; Tacrolimus tablets; Tacrolimus with methotrexate; | 2件: D00107 D00107
D08556 D08556 💬 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
361 | TAK-715 | Tak-715 2件: Tak-715; Tak-715 and methotrexate; | - |
- |
- |
046 1件: 46 💬 |
362 | Tea leaf | Green tea leaf 2件: Green tea leaf; Tea leaf; | - |
- |
- |
017 2件: 17, 46 💬 |
363 | Technetium Tc-99m | - | - |
- |
- |
046 2件: 46, 98 💬 |
364 | Technetium Tc-99m tilmanocept | - | - |
- |
- |
046 1件: 46 💬 |
365 | Tegafur | - | 1件: D01244 D01244 💬 |
1件: TYMS 💬 |
Antifolate resistance 4件: Antifolate resistance, Metabolic pathways, One carbon pool by folate, Pyrimidine metabolism |
046 1件: 46 💬 |
366 | Tenamfetamine | - | - |
- |
- |
046 1件: 46 💬 |
367 | Teriparatide | Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) 6件: Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1); Teriparatide; Teriparatide (forteo); Teriparatide [rdna origin] contains recombinant human parathyroid hormone (1-34); Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker; Teriparatide pen injector; | 1件: D06078 D06078 💬 |
1件: PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
046 7件: 46, 65, 68, 70, 71, 235, 274 💬 |
368 | Tetracycline | Amoxicillin and tetracycline 4件: Amoxicillin and tetracycline; Amoxicillin, metronidazole and tetracycline; Tetracycline; Tetracycline - statin - antimycotic; | 1件: D00201 D00201 💬 |
- |
- |
013 5件: 13, 36, 46, 53, 97 💬 |
369 | Tetrandrine | Tetrandrine 1件: Tetrandrine; | - |
- |
- |
046 2件: 46, 85 💬 |
370 | Ticagrelor | Ticagrelor 1件: Ticagrelor; | 1件: D09017 D09017 💬 |
1件: P2RY12 💬 |
Platelet activation 1件: Platelet activation |
036 3件: 36, 46, 85 💬 |
371 | Tilmanocept | Tc 99m tilmanocept 4件: Tc 99m tilmanocept; Tc99m-tilmanocept; Technetium tc 99m tilmanocept; Tilmanocept; | - |
- |
- |
046 1件: 46 💬 |
372 | Tirabrutinib | Tirabrutinib 1件: Tirabrutinib; | - |
- |
- |
035 3件: 35, 46, 53 💬 |
373 | Titanium | Device: interbody cage (titanium) 3件: Device: interbody cage (titanium); Device: titanium cage; Titanium; | - |
- |
- |
046 3件: 46, 69, 70 💬 |
374 | Tocilizumab | Abatacept, rituximab or tocilizumab 39件: Abatacept, rituximab or tocilizumab; Adalimuab, etanercept, tocilizumab, or abatacept; Corticoids+ tocilizumab 8mg/kg/4 weeks; Decrease tocilizumab, abatacept; Etanercepet, rituximab, abatacept, tocilizumab, sarilumab; Inn-tocilizumab; Intra-articular tocilizumab; Mra (tocilizumab); Mra(tocilizumab); Subcutaneous tocilizumab; Tocilizumab; Tocilizumab (actemra or roactemra); Tocilizumab (actemra); Tocilizumab (actemra®); Tocilizumab (mra-sc); Tocilizumab (tcz); Tocilizumab + glucocorticoids (gcs); Tocilizumab + methotrexate(mtx); Tocilizumab 162 mg; Tocilizumab 162mg/0.9ml jeringa sc; Tocilizumab 162mg/0.9ml sc pfs sc; Tocilizumab 162mg/0.9ml syringe sc; Tocilizumab [roactemra/actemra]; Tocilizumab [roactemra]; Tocilizumab and iv steroids combination; Tocilizumab infusion roacemtra (eu); Tocilizumab injection; Tocilizumab iv; Tocilizumab plus methotrexate; Tocilizumab prefilled syringe; Tocilizumab roche; Tocilizumab sc; Tocilizumab sc 162 mg/0.9 ml disposable auto-injector (ai); Tocilizumab sc 162 mg/0.9 ml pre-filled syringe with safety device (pfs); Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs); Tocilizumab treatment; Tocilizumab+methotrexate(mtx); Tocilizumab, abatacept; Tocilizumabum; | 1件: D02596 D02596 💬 |
1件: IL6R 💬 |
Coronavirus disease - COVID-19 12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
375 | Tofacitinib | 15n2-tofacitinib 36件: 15n2-tofacitinib; Chong kun dang tofacitinib tablet; Cp-690,550 (tofacitinib); In double-blind phase: treatment with tofacitinib; In open-label phase: treatment with tofacitinib; Tofacitinib; Tofacitinib (cp-690,550); Tofacitinib (xeljanz); Tofacitinib (xeljanz®); Tofacitinib (xeljanz®) 11mg prolonged release tablet; Tofacitinib 10 mg; Tofacitinib 2 mg; Tofacitinib 5 mg; Tofacitinib 5 mg [xeljanz]; Tofacitinib 5 mg twice daily; Tofacitinib 5mg [xeljanz] 1 year open-label extension; Tofacitinib 5mg oral tablet [xeljanz] 16 week trial; Tofacitinib 5mg po bid; Tofacitinib citate (phase iii formulation); Tofacitinib citrate; Tofacitinib citrate (clinical trial image); Tofacitinib citrate (commercial image); Tofacitinib citrate (phase iii formulation); Tofacitinib citrate (proposed commercial formulation - debossed); Tofacitinib citrate (proposed commercial formulation debossed); Tofacitinib citrate (proposed commercial formulation – debossed); Tofacitinib citrate (proposed commercial formulation- debossed); Tofacitinib citrate (proposed commercialformulation - debossed); Tofacitinib citrate cp-690550; Tofacitinib citrate( phase iii formulation); Tofacitinib or baricitinib; Tofacitinib tablet; Tofacitinib with methotrexate; Tofacitinib without methotrexate; Tofacitinib/baricitinib; Tofacitinibe citrate; | 1件: D09970 D09970 💬 |
4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
376 | Topramezone | - | - |
- |
- |
006 8件: 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
377 | Tramadol | Amitriptyline, fluoxetine and tramadol alone (control group) 6件: Amitriptyline, fluoxetine and tramadol alone (control group); Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group); Tramadol; Tramadol /acetaminophen; Tramadol hydrochloride + acetaminophen; Tramadol with ropivacaine; | 2件: D01355 D01355
D08623 D08623 💬 |
1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 5件: 46, 70, 78, 226, 271 💬 |
378 | Tranexamic acid | Tranexamic acid 3件: Tranexamic acid; Tranexamic acid 100 mg/ml; Tranexamic acid injection [cyklokapron]; | 1件: D01136 D01136 💬 |
1件: PLG 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
046 5件: 46, 70, 215, 227, 288 💬 |
379 | Tranilast | Tranilast 1件: Tranilast; | 1件: D02027 D02027 💬 |
- |
- |
046 4件: 46, 84, 106, 113 💬 |
380 | Tregalizumab | Tregalizumab 1件: Tregalizumab; | - |
- |
- |
046 1件: 46 💬 |
381 | Triamcinolone | Bladder instillation with triamcinolone acetonide 11件: Bladder instillation with triamcinolone acetonide; Bladder instillation without triamcinolone acetonide; Intra plexus triamcinolone and bupivicaine injection; Procedure: celiac block with triamcinolone and bupivicaine; Triamcinolone; Triamcinolone 40 milligrams (kenacort, bristol myers squip); Triamcinolone acetonide; Triamcinolone acetonide and normal saline solution; Triamcinolone hexacetonid (lederspan); Triamcinolone hexacetonide; Triamcinolone hexacetonide (lederspan); | 5件: D00385 D00385
D00983 D00983
D00984 D00984
D00985 D00985
D06216 D06216 💬 |
1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬 |
382 | Tripterygium wilfordii whole | - | - |
- |
- |
046 8件: 46, 66, 67, 96, 162, 222, 224, 271 💬 |
383 | TRU-015 | Tru-015 1件: Tru-015; | - |
- |
- |
046 3件: 46, 49, 222 💬 |
384 | Ubidecarenone | - | 1件: D01065 D01065 💬 |
- |
- |
002 13件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 86, 113, 193, 214, 215 💬 |
385 | Upadacitinib | Upadacitinib 9件: Upadacitinib; Upadacitinib (abt-494); Upadacitinib - direct compression-yellow; Upadacitinib - wet granulation-yellow; Upadacitinib -direct compression-yellow; Upadacitinib 12mg; Upadacitinib 15mg; Upadacitinib 30mg; Upadacitinib 3mg; | 1件: D10994 D10994 💬 |
1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
040 7件: 40, 41, 46, 49, 96, 97, 271 💬 |
386 | Ustekinumab | Evaluation of biological predictive factors of clinical response to ustekinumab 36件: Evaluation of biological predictive factors of clinical response to ustekinumab; Group 2 ustekinumab 130 mg; Group 3: ustekinumab approximately 6 mg/kg; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Prednisone and ustekinumab treatment; Stelara (ustekinumab); Subcutaneous ustekinumab; Ustekinumab; Ustekinumab (6 mg/kg); Ustekinumab (90 mg); Ustekinumab (approximately 6 mg/kg); Ustekinumab + mtx (group 2); Ustekinumab + mtx (group 3); Ustekinumab 130 mg iv; Ustekinumab 180 mg; Ustekinumab 1mg/kg (ip); Ustekinumab 3 mg/kg (ip); Ustekinumab 4.5 mg/kg; Ustekinumab 45 mg; Ustekinumab 6 mg/kg; Ustekinumab 6 mg/kg (ip); Ustekinumab 90 mg; Ustekinumab 90 mg (sc) group 1; Ustekinumab 90 mg (sc) group 2; Ustekinumab 90 mg sc q12w; Ustekinumab 90 mg sc q8w; Ustekinumab 90 milligram (mg); Ustekinumab approximately 6 mg/kg (iv); Ustekinumab dose based on bsa and body weight; Ustekinumab iv; Ustekinumab iv - nonresponder - ustekinumab 90mg sc (mp); Ustekinumab iv - responder - ustekinumab 90mg sc (mp); Ustekinumab iv infusion; Ustekinumab liquid in prefilled syringe; Ustekinumab sc; Ustekinumab sc injection; | 1件: D09214 D09214 💬 |
3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
387 | Valdecoxib | Valdecoxib 1件: Valdecoxib; | 1件: D02709 D02709 💬 |
1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
388 | Vancomycin | Inhaled vancomycin 10件: Inhaled vancomycin; Iv vancomycin hydrochloride; Oral vancomycin; Vancomycin; Vancomycin hydrochloride inhalation powder; Vancomycin inhalation powder; Vancomycin pre-treat; Vancomycin pre-treatment; With u-vanco (vancomycin hydrochloride); Without u-vanco (vancomycin hydrochloride); | 2件: D00212 D00212
D00926 D00926 💬 |
- |
- |
046 7件: 46, 70, 94, 96, 97, 296, 299 💬 |
389 | Varicella Zoster Vaccine (Live/attenuated) | - | - |
- |
- |
046 2件: 46, 49 💬 |
390 | Varicella Zoster Vaccine (Recombinant) | - | - |
- |
- |
046 3件: 46, 96, 97 💬 |
391 | Veltuzumab | Veltuzumab 2件: Veltuzumab; Veltuzumab solution 75mg/ml; | 1件: D09031 D09031 💬 |
1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
046 1件: 46 💬 |
392 | Venlafaxine | Efexor xl 75 mg (venlafaxine) 3件: Efexor xl 75 mg (venlafaxine); Venlafaxine; Venlafaxine hydrochloride; | 2件: D00821 D00821
D08670 D08670 💬 |
2件: SLC6A2, SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 3件: 6 , 13, 46 💬 |
393 | Vidofludimus | Vidofludimus 3件: Vidofludimus; Vidofludimus calcium; Vidofludimus calcium dihydrate; | - |
- |
- |
013 5件: 13, 46, 94, 96, 97 💬 |
394 | Vitamin D | 10000iu vitamin d 36件: 10000iu vitamin d; 19 nor vitamin d; 25-hydroxyvitamin d3; 25oh-vitamin d; 5000iu vitamin d; Alendronate versus alfacalcidol (1-alpha oh vitamin d); Calcium and vitamin d combination; Cholecalciferol (vitamin d3); Cholecalciferol, vitamin d3; D6-25-hydroxyvitamin d3; Diagnostic test: vitamin d measurement; Ergocalciferol (vitamin d2); High-dose vitamin d (2000 iu per day); High-dose vitamin d3; Low dose arm receiving neutral oil and 400 iu/g of vitamin d every second day; Other: baseline serum vitamin d level at or above 50 nmol/l; Other: baseline serum vitamin d level below 50 nmol/l; Standard-dose vitamin d (400iu per day); Supplementation with vitamin d2/d3; Verum arm receiving vitamin d oil; Vitamin d; Vitamin d 100ug; Vitamin d 10ug; Vitamin d 25(oh)d; Vitamin d drops; Vitamin d in arm b; Vitamin d oil; Vitamin d powder; Vitamin d2; Vitamin d3; Vitamin d3 3000 ui daily; Vitamin d3 400 iu; Vitamin d3 4000 ui daily; Vitamin d3 6000 iu; Vitamin d3 800 ui/day then 800 ui/day; Vitamin d3: 3000 or 4000 ui/day then 2,000 ui/day; | - |
- |
- |
013 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
395 | Vitamin E | Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e) 9件: Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e); Coenzyme q10 with vitamin e; Omega-3 and vitamin e supplementation; Vitamin c 10mg/kg vitamin e 10 mg/kg; Vitamin e; Vitamin e - tgps; Vitamin e 800iu; Vitamin e supplement; Vitamin e/selenium; | 1件: D02331 D02331 💬 |
- |
- |
002 12件: 2 , 6 , 13, 20, 46, 49, 90, 96, 97, 206, 299, 317 💬 |
396 | VX-702 | Vx-702 1件: Vx-702; | - |
- |
- |
046 1件: 46 💬 |
397 | Warfarin | S-warfarin 6件: S-warfarin; The generic name is warfarin and many producers will be involved; Warfarin; Warfarin 10 mg; Warfarin sodium; Warfarin+ vitamin k; | 3件: D00564 D00564
D01280 D01280
D08682 D08682 💬 |
2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
398 | Water | 15 o water 31件: 15 o water; 15-o labeled water; 5% glucose water solution; Behavioral: diet and water adjustment; Behavioral: water tracking; Cholecalciferol concentrate (water-dispersible form); Device: manual toothbrush and water flosser (philips sonicare airfloss); Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss); Dextrose, 5% in water; High water intake; Lactose in water; Other: ad libitum water intake; Other: dead sea solar and water treatment; Other: dextrose water 5%; Other: exercise followed cold water immersion; Other: harkány medicinal water; Other: high water intake; Other: potable water; Other: water; Other: water prescription; Pl 12185/0002 & pl 12185/0005(water for injection); Procedure: water exercises; Pseudoephedrine + 480 ml water; Pseudoephedrine + 50 ml water; Sterile water; Sterile water for injection; Sterilised water for injections; Water; Water for injection; Water for injections; Water for injections, ep; | 1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
399 | Yellow Fever Vaccine | Yellow fever vaccine 2件: Yellow fever vaccine; Yellow fever vaccine (17d); | 1件: D06347 D06347 💬 |
- |
- |
040 7件: 40, 44, 46, 50, 51, 52, 53 💬 |
400 | Zoledronic acid | Lonafarnib, zoledronic acid, and pravastatin 8件: Lonafarnib, zoledronic acid, and pravastatin; Zoledronic acid; Zoledronic acid 5mg/bag 100ml inj; Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product; Zoledronic acid kern pharma 4 mg/100 ml solution for infusion, generic medicinal product.; Zoledronic acid kern pharma 4 mg/100 ml solution for infusion,generic medicinal product; Zoledronic acid monohydrate; Zoledronic acid, pravastatin; | 4件: D01968 D01968
D06378 D06378
D06379 D06379
D08689 D08689 💬 |
1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 10件: 6 , 13, 46, 65, 93, 95, 96, 274, 299, 333 💬 |
401 | Zolpidem | Zolpidem 4件: Zolpidem; Zolpidem first dose; Zolpidem second dose; Zolpidem tartrate; | 2件: D00706 D00706
D08690 D08690 💬 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
005 3件: 5 , 6 , 46 💬 |